Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,7.698386425261231e-40,29.796934865900383,2683.5832571353008,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS6KA6', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS6KB1', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.31109639814629e-37,0,0,77
2,Oxidative phosphorylation WP623,8.299857596763527e-11,6.640079760717846,154.1308439191112,"['NDUFB9', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFV2', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFS1']",2.3239601270937875e-08,0,0,33
3,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.3994775178242938e-10,4.134401874913107,93.80855306346764,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'COX4I1', 'NDUFB4', 'COX17', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1A', 'ATP5F1B', 'NDUFV2', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS1', 'SLC25A5', 'SLC25A4', 'SLC25A6']",2.612358033272015e-08,0,0,47
4,Nonalcoholic fatty liver disease WP4396,8.082562707902774e-07,2.544509119130772,35.695357787877775,"['NDUFA13', 'COX7B', 'NDUFA11', 'COX4I1', 'PRKAG1', 'COX7C', 'AKT3', 'LEPR', 'RAC1', 'MAP3K5', 'NDUFC2', 'NDUFC1', 'PRKAB1', 'COX6B1', 'PIK3CA', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS1', 'PPARA', 'ATF4', 'NDUFB9', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX7A1', 'UQCRH', 'CDC42', 'NDUFV2', 'NDUFV1', 'XBP1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'COX6C', 'NFKB1', 'CYCS', 'BAX', 'MAP3K11']",0.00011315587791063884,0,0,52
5,Mitochondrial complex I assembly model OXPHOS system WP4324,0.0001681569733419868,3.0112905130172973,26.16995942428203,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFS1', 'NDUFV2', 'NDUFV1']",0.01883358101430252,0,0,23
6,Proximal tubule transport WP4917,0.0002286702899999834,4.2487566947207345,35.618301924254574,"['ATP6V1A', 'ATP6V1G1', 'ATP6V0B', 'ABCB1', 'SLC20A2', 'SLC1A1', 'SLC3A1', 'SLC3A2', 'ATP1A1', 'ATP1B1', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1C1', 'ATP6V1F']",0.02134256039999845,0,0,15
7,Synaptic Vesicle Pathway WP2267,0.0005121665797060524,2.8575460122699385,21.65122789264509,"['UNC13C', 'RAB3A', 'SLC32A1', 'SYT1', 'STXBP1', 'CLTC', 'CLTA', 'PARK7', 'SYP', 'AP2B1', 'SYN3', 'SYN2', 'DNM2', 'CPLX3', 'DNM3', 'RIMS1', 'SLC17A7', 'STX3', 'SLC17A8', 'SLC25A4', 'AP2M1']",0.04097332637648419,0,0,21
8,Photodynamic therapy-induced unfolded protein response WP3613,0.0012174261288284386,4.075047764615973,27.34771229485673,"['NARS', 'XBP1', 'WARS', 'HSPA5', 'DDIT3', 'UBE2E1', 'DNAJB9', 'CALR', 'PDIA6', 'HSP90B1', 'EIF2A', 'ATF4']",0.0852198290179907,0,0,12
9,Regulation of Microtubule Cytoskeleton WP2038,0.0015539968612319995,2.7810661188677273,17.98494614101811,"['TRIO', 'ROCK1', 'SRC', 'PRKCA', 'CDC42', 'TIAM1', 'PIK3CA', 'CFL2', 'DPYSL2', 'TAOK1', 'GNAQ', 'STMN1', 'ABL1', 'RAC1', 'MAPT', 'PRKACA', 'CLASP1', 'MARK1']",0.0966931380322133,0,0,18
10,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0021149912085189344,5.090267175572519,31.349451987629443,"['EIF5', 'EIF2S3', 'EIF1AX', 'EIF3I', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF3D', 'EIF1']",0.11843950767706032,0,0,9
11,Proteasome Degradation WP183,0.002401456873101171,2.3378164556962027,14.10096004724955,"['UBE2B', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMA7', 'PSMD8', 'PSMA5', 'PSMB6', 'PSMB7', 'PSMA3', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMC6', 'PSMB2', 'PSMA2', 'PSMD2', 'PSME3', 'PSMC1', 'PSME2']",0.1222559862669687,0,0,22
12,Cellular Proteostasis WP4918,0.0029924069578619967,16.951219512195124,98.51501616804164,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5']",0.13964565803355983,0,0,5
13,Glycolysis and Gluconeogenesis WP534,0.0033305587866272425,3.1530963302752295,17.987201206323903,"['PDHA1', 'GOT1', 'MDH2', 'PGAM1', 'GOT2', 'SLC2A3', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'PFKM', 'PFKP']",0.143470224654712,0,0,13
14,Translation Factors WP107,0.0038672766058199526,2.391514119483468,13.285350570163718,"['EIF4A2', 'EIF4A1', 'EIF1AX', 'EIF2AK2', 'EIF2S2', 'EIF1', 'EEF1B2', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF2S3', 'EIF3I', 'EIF3J', 'EIF4H', 'EIF3F', 'EIF3D', 'EIF4G3', 'EIF4B', 'EIF4G1']",0.15255105192713125,0,0,19
15,Exercise-induced Circadian Regulation WP410,0.0043370583715573886,2.5111192489513283,13.66189231757889,"['NCKAP1', 'IDI1', 'DAZAP2', 'GSTM3', 'CEBPB', 'BTG1', 'QKI', 'AZIN1', 'HERPUD1', 'DNAJA1', 'PURA', 'SUMO1', 'CRY2', 'CRY1', 'TAB2', 'ERC2', 'EIF4G2']",0.15255105192713125,0,0,17
16,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.004358601483632322,5.935450038138826,32.2627561691956,"['RYR1', 'RYR2', 'DAGLA', 'GNAQ', 'ITPR1', 'CCK', 'PLCB1']",0.15255105192713125,0,0,7
17,Airway smooth muscle cell contraction WP4962,0.008411573618665586,4.747826086956522,22.685809595612515,"['RYR1', 'PPP1R14A', 'ROCK1', 'GNAQ', 'PLCB1', 'CALM1', 'MYLK']",0.26440680064533734,0,0,7
18,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.008498790020742986,8.474657012195122,40.405736452060616,"['GALNT3', 'SPP1', 'FAM20C', 'NFKB1', 'FGFR2']",0.26440680064533734,0,0,5
19,miR-517 relationship with ARCN1 and USP1 WP3596,0.011856299128960867,inf,inf,"['ID2', 'USP1', 'ARCN1']",0.3494488164325308,0,0,3
20,Myometrial relaxation and contraction pathways WP289,0.013789933738690184,1.6309502434490553,6.986691387773395,"['ATF1', 'RYR1', 'RYR2', 'CAMK2D', 'YWHAB', 'RGS16', 'ITPR1', 'ITPR2', 'ATP2A2', 'ADCY2', 'ADCY8', 'SLC8A1', 'ACTG1', 'YWHAQ', 'PRKACA', 'RGS7', 'GSTO1', 'IGFBP3', 'PRKCE', 'PDE4D', 'PRKCA', 'NFKB1', 'CREB3', 'ADCY9', 'PRKAR1A', 'GNB2', 'GNAQ', 'GNB1', 'CRH', 'CALM3', 'PRKD1', 'GNB5', 'ATF5', 'CALM1', 'ATF4']",0.38611814468332517,0,0,35
21,Aryl Hydrocarbon Receptor Pathway WP2873,0.015727878173830333,2.8270968563064782,11.739012122862565,"['NCOA1', 'SLC7A5', 'HSP90AA1', 'CDKN1B', 'TGFB1', 'SRC', 'CDC37', 'AIP', 'EP300', 'BAX']",0.4194100846354756,0,0,10
22,Leptin and adiponectin WP3934,0.018420251281466498,5.649136178861789,22.564370661829958,"['PRKAG1', 'LEPR', 'ADIPOR1', 'PRKAB1', 'ACACA']",0.42980586323421827,0,0,5
23,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.018420251281466498,5.649136178861789,22.564370661829958,"['SFRP1', 'ZEB2', 'TGFB1', 'NRG3', 'ERBB4']",0.42980586323421827,0,0,5
24,miR-509-3p alteration of YAP1/ECM axis WP3967,0.018420251281466498,5.649136178861789,22.564370661829958,"['EDNRA', 'SPARC', 'PBX3', 'GPC6', 'TEAD1']",0.42980586323421827,0,0,5
25,Pregnane X receptor pathway WP2876,0.02364975241899823,3.3905415713196034,12.695552785725475,"['NCOA1', 'NCOA2', 'HSP90AA1', 'PSMC5', 'ABCB1', 'SRC', 'FOXO1']",0.5297544541855603,0,0,7
26,Fragile X Syndrome  WP4549,0.027566962826105247,1.5255372358302197,5.47841355157741,"['CYFIP2', 'GRIA1', 'EIF4A1', 'SRC', 'CLTC', 'ITPR1', 'CLTA', 'ABAT', 'SLC6A1', 'RPTOR', 'GRIP1', 'PPP3CA', 'GRM5', 'FYN', 'PRKACA', 'AP2M1', 'NTRK2', 'MAP2K1', 'KCND2', 'GAD1', 'GAB1', 'PPP2R5B', 'PRKCA', 'BRAF', 'AP2B1', 'GRIN2B', 'DNM2', 'EEF1A1', 'ARHGAP32', 'ALDH5A1', 'RPS6KB1', 'PRKAR1A', 'PLCB1', 'EIF4G1', 'HCN1']",0.550472448096916,0,0,35
27,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.030528169294552033,2.422680412371134,8.452987401780126,"['ATF1', 'CREB3', 'CAMK2D', 'CAMK1D', 'GNAQ', 'ITPR1', 'ITPR2', 'CALM3', 'CALM1', 'ATF4']",0.550472448096916,0,0,10
28,Cytosolic DNA-sensing pathway WP4655,0.030963433074428195,2.100407747196738,7.298808433329703,"['DDX58', 'POLR3GL', 'ADAR', 'ISG15', 'NFKB1', 'POLR1C', 'POLR2E', 'TRIM25', 'POLR2F', 'POLR3H', 'POLR3K', 'POLR2K', 'NFKBIB']",0.550472448096916,0,0,13
29,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.03205736915846115,1.9578747572244128,6.735535942284924,"['PPP1R16B', 'PPP1R14A', 'XBP1', 'PPP1R13B', 'PPP1R12A', 'HSPA5', 'EIF2AK2', 'PPP1R9A', 'PPP1R2', 'PPP1R3F', 'MAP1LC3A', 'PPP1R3E', 'DDIT3', 'PPP1R8', 'ATF4']",0.550472448096916,0,0,15
30,Alanine and aspartate metabolism WP106,0.03374264012600751,4.236375762195122,14.357047616137198,"['GOT1', 'GAD1', 'GOT2', 'GAD2', 'ABAT']",0.550472448096916,0,0,5
31,Biomarkers for pyrimidine metabolism disorders WP4584,0.03374264012600751,4.236375762195122,14.357047616137198,"['NT5C', 'DPYD', 'TK2', 'CKB', 'UMPS']",0.550472448096916,0,0,5
32,Target Of Rapamycin (TOR) Signaling WP1471,0.034007958047622806,2.1425899483136575,7.2444409755822665,"['RPTOR', 'CDC42', 'IDI1', 'RRAGA', 'RPS6KB1', 'RRAGC', 'RRAGD', 'PRKAG1', 'RICTOR', 'PRKCA', 'RAC1', 'PRKAB1']",0.550472448096916,0,0,12
33,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.03451125780414256,2.712552460892789,9.131725655719915,"['EGLN1', 'LDHA', 'PDHA1', 'PRKAG1', 'PDHB', 'PRKAB1', 'ACACB', 'ACACA']",0.550472448096916,0,0,8
34,VEGFA-VEGFR2 Signaling Pathway WP3888,0.03553164656263614,1.266193853427896,4.225708666515689,"['RPL5', 'ARF4', 'ITGB5', 'TRAF3IP2', 'CLTC', 'LDB2', 'RPL10A', 'SLC8A1', 'RPL7', 'HERPUD1', 'ACTG1', 'PPP3CA', 'RPL18A', 'TMSB4X', 'RACK1', 'RPLP2', 'ELOC', 'RAC1', 'ATP6V1E1', 'ACP1', 'HRAS', 'MAP3K5', 'EIF2A', 'TMOD1', 'MEF2C', 'MAP2K1', 'HSP90AA1', 'SSR4', 'TRPC3', 'PRKCE', 'IGFBP3', 'SSR3', 'GAB1', 'SARS', 'RPL13A', 'PRKCA', 'PDIA6', 'SND1', 'PIK3CA', 'KATNAL2', 'NUMB', 'MYH9', 'RPL27', 'PRKD1', 'RPL26', 'TKT', 'ATP6V0D1', 'PTMA', 'ATF4', 'LRRC59', 'SET', 'ROCK1', 'SRC', 'EPB41', 'PXN', 'TXN', 'ACACB', 'FOXO1', 'ACACA', 'CDC42', 'LDHA', 'DHX36', 'PGK1', 'ABL1', 'DNAJB9', 'RICTOR', 'FYN', 'ASCC3', 'CCT7', 'ABCF2', 'SLC25A25', 'ZC3H15', 'TXNDC5', 'STAT1', 'PDE4DIP', 'NFKB1', 'QKI', 'RAB11A', 'DNAJA1', 'AFDN', 'RPS6KB1', 'PTPN9', 'CYCS', 'HYOU1', 'EIF3F', 'CALR', 'COPG1', 'GRSF1', 'EIF3D', 'EIF4G2', 'EIF4G1']",0.550472448096916,0,0,91
35,Mitochondrial complex III assembly WP4921,0.035782953854111704,2.9663901601830664,9.878920644926957,"['UQCRB', 'UQCC3', 'UQCC2', 'LYRM7', 'UQCR11', 'UQCR10', 'UQCRH']",0.550472448096916,0,0,7
36,GABA receptor Signaling WP4159,0.03728092608903956,2.194760257043994,7.219166638284324,"['GABRA2', 'GABRB1', 'GABBR1', 'SLC32A1', 'GAD1', 'GAD2', 'ABAT', 'AP2B1', 'SLC6A1', 'GABRG3', 'AP2M1']",0.550472448096916,0,0,11
37,Pyrimidine metabolism WP4022,0.03859423916501039,1.6600093764650727,5.402753265544682,"['POLR3GL', 'NME2', 'NME3', 'NME4', 'NT5C', 'POLE4', 'NME6', 'POLR2A', 'NME7', 'POLR1C', 'DPYD', 'POLR2D', 'TWISTNB', 'POLD2', 'POLR2E', 'TK2', 'POLR2G', 'POLR3H', 'UMPS', 'DCTPP1', 'POLR3K', 'POLR2K']",0.550472448096916,0,0,22
38,ACE Inhibitor Pathway WP554,0.03931946057835114,10.162985529322164,32.88778401746092,"['TGFB1', 'ATP6AP2', 'NR3C2']",0.550472448096916,0,0,3
39,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.03931946057835114,10.162985529322164,32.88778401746092,"['ID2', 'TCF4', 'RUNX2']",0.550472448096916,0,0,3
40,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.03931946057835114,10.162985529322164,32.88778401746092,"['SRC', 'SLIT2', 'RAC1']",0.550472448096916,0,0,3
41,PKC-gamma calcium signaling pathway in ataxia WP4760,0.0480007028967722,2.465679303527453,7.487132906467492,"['GRIA1', 'PLCB4', 'TRPC3', 'GNAQ', 'ITPR1', 'PLCB1', 'GRIA3', 'GRIA4']",0.594698961136357,0,0,8
42,Mitochondrial CIV Assembly WP4922,0.048049915970883504,2.0725957049486463,6.291395128197045,"['COA3', 'COX7B', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX14', 'COX6C', 'COX7C', 'PET117', 'COX6B1']",0.594698961136357,0,0,11
43,Methionine De Novo and Salvage Pathway WP3580,0.05139875989919772,2.636494618187982,7.825488387582537,"['MSRA', 'AHCY', 'AMD1', 'ODC1', 'SMS', 'TXN', 'SRM']",0.594698961136357,0,0,7
44,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.0520109262161291,inf,inf,"['TGFB1', 'VIP']",0.594698961136357,0,0,2
45,EV release from cardiac cells and their functional effects WP3297,0.0520109262161291,inf,inf,"['ERBB4', 'RGS16']",0.594698961136357,0,0,2
46,Gastric acid production WP2596,0.0520109262161291,inf,inf,"['CCK', 'VIP']",0.594698961136357,0,0,2
47,Nanomaterial-induced inflammasome activation WP3890,0.0520109262161291,inf,inf,"['NFKB1', 'CTSB']",0.594698961136357,0,0,2
48,Osteoclast Signaling WP12,0.05203615909943123,4.517587301587302,13.353158791493806,"['AIMP2', 'ATP6V1G1', 'SPP1', 'IFNAR1']",0.594698961136357,0,0,4
49,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.05203615909943123,4.517587301587302,13.353158791493806,"['CAMK2D', 'MEF2C', 'CCND2', 'MEF2D']",0.594698961136357,0,0,4
50,RalA downstream regulated genes WP2290,0.055039149878191064,3.388719512195122,9.826305656128845,"['CDC42', 'RALBP1', 'RAC1', 'HRAS', 'EXOC2']",0.6164384786357399,0,0,5
51,mRNA Processing WP411,0.056791084771753486,1.4059071505512188,4.032670221764744,"['SF3B5', 'SF3B3', 'DHX8', 'SFSWAP', 'RNMT', 'CELF2', 'CSTF2T', 'SNU13', 'YBX1', 'PRPF8', 'POLR2A', 'SNRPD1', 'SNRPB2', 'TXNL4A', 'HNRNPA1', 'SF3B1', 'SRPK2', 'SF3A1', 'RNGTT', 'CPSF1', 'NCBP2', 'SUPT5H', 'PTBP2', 'PRPF4', 'HNRNPM', 'LSM7', 'PRPF6', 'HNRNPK', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPA1', 'SNRPF', 'CLASRP', 'RBMX', 'SRSF9']",0.6235883818074892,0,0,36
52,Selenium Micronutrient Network WP15,0.060327423946222467,1.8372356014271152,5.158899671678717,"['GPX4', 'TXN', 'KMO', 'SELENOK', 'NFKB1', 'SELENOH', 'SOD1', 'SELENOM', 'SELENOS', 'SELENOW', 'PNPO', 'SELENOT', 'SEPHS2']",0.6496799501900882,0,0,13
53,Cell migration and invasion through p75NTR WP4561,0.06449413107682665,2.2599516723896733,6.194936699123058,"['NTRK2', 'TIAM1', 'ARF1', 'TRIO', 'EFNB3', 'AKT3', 'RAC1', 'EFNA5']",0.6663460823006152,0,0,8
54,Endothelin Pathways WP2197,0.06449413107682665,2.2599516723896733,6.194936699123058,"['EDNRA', 'MAP2K1', 'ATP2A2', 'PRKCA', 'GNB5', 'PLCB1', 'CALM1', 'MYLK']",0.6663460823006152,0,0,8
55,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.06544470451166756,1.7587989519155867,4.795452752616608,"['EIF4A2', 'EIF4A1', 'MAP2K1', 'PRKCA', 'RPTOR', 'MAPK10', 'RPS6KB1', 'PIK3CA', 'RPS6KA2', 'AKT3', 'PRKACA', 'EIF4G3', 'EIF4B', 'EIF4G1']",0.6663460823006152,0,0,14
56,Genotoxicity pathway WP4286,0.0674209314350386,1.8497933094799737,4.988522141697883,"['COIL', 'RPS27', 'GADD45A', 'EI24', 'BLOC1S2', 'ID2', 'SEL1L', 'PCDH8', 'ITPR1', 'RAPGEF2', 'PPM1D', 'PRKAB1']",0.674209314350386,0,0,12
57,Splicing factor NOVA regulated synaptic proteins WP4148,0.07324813879310553,1.7635474006116207,4.60974085417679,"['NTNG1', 'KCNJ6', 'CADM1', 'EPB41', 'APLP2', 'CLSTN1', 'ANK3', 'EFNA5', 'GRIN2B', 'PLCB4', 'CDH2', 'TERF2IP', 'CLASP1']",0.7196308372655982,0,0,13
58,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.07542838428833913,2.0340458015267178,5.257137063308742,"['EGLN1', 'LDHA', 'PDHA1', 'PKM', 'IGFBP3', 'PGK1', 'BAX', 'SLC2A3', 'HIF1AN']",0.7282740551977571,0,0,9
59,Endochondral Ossification with Skeletal Dysplasias WP4808,0.07833742979222942,1.6957934990439771,4.31872777024221,"['MEF2C', 'TGFB1', 'THRA', 'STAT1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'SPP1', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'SOX5']",0.7308114616814115,0,0,14
60,Endochondral Ossification WP474,0.07833742979222942,1.6957934990439771,4.31872777024221,"['MEF2C', 'TGFB1', 'THRA', 'STAT1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'SPP1', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'SOX5']",0.7308114616814115,0,0,14
61,Mitochondrial fatty acid synthesis pathway WP4317,0.08172749781832069,5.080921553693831,12.724480903347743,"['HSD17B12', 'MCAT', 'ACACA']",0.7308114616814115,0,0,3
62,Cell Differentiation - Index expanded WP2023,0.08244576104183171,2.8236153455284554,7.046655804669982,"['SOX2', 'MEF2C', 'ID2', 'MEF2D', 'RUNX2']",0.7308114616814115,0,0,5
63,Cori Cycle WP1946,0.08244576104183171,2.8236153455284554,7.046655804669982,"['LDHA', 'PGAM1', 'PGK1', 'TALDO1', 'PFKP']",0.7308114616814115,0,0,5
64,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.08352130990644703,1.5348020434227332,3.810381620746708,"['MAP2K1', 'THRA', 'SRC', 'ITPR2', 'ADCY8', 'FOXO1', 'RPTOR', 'CREB3', 'RPS6KA6', 'TBC1D4', 'PIK3CA', 'RPS6KB1', 'AKT3', 'PPARG', 'PRKACA', 'PLCB1', 'MAP4K5', 'HRAS', 'MGLL']",0.7308114616814115,0,0,19
65,Pathways in clear cell renal cell carcinoma WP4018,0.08600918917430622,1.5079425918827989,3.699437276060472,"['SETD2', 'TGFB1', 'BHLHE41', 'PLOD2', 'ACACB', 'ACACA', 'RPTOR', 'LDHA', 'PKM', 'ZEB1', 'PGK1', 'EP300', 'CDH13', 'ALDOC', 'VHL', 'CEP290', 'SQSTM1', 'PFKM', 'KCNJ2', 'PFKP']",0.7410022451940228,0,0,20
66,Eukaryotic Transcription Initiation WP405,0.08783205185942383,1.6955275229357798,4.124080407614597,"['GTF2A2', 'GTF2H2C', 'ILK', 'GTF2H3', 'POLR2A', 'POLR2E', 'POLR2F', 'TAF7', 'POLR2G', 'POLR3H', 'MNAT1', 'POLR3K', 'POLR2K']",0.7452416521405658,0,0,13
67,G Protein Signaling Pathways WP35,0.0919071077298615,1.4453042835621501,3.449907953669397,"['PDE4D', 'PRKCE', 'ITPR1', 'PRKCA', 'AKAP6', 'ADCY2', 'ADCY8', 'AKAP13', 'PPP3CA', 'GNG10', 'ADCY9', 'PRKAR1A', 'GNB2', 'GNAQ', 'AKAP9', 'GNB1', 'PRKD1', 'GNB5', 'PRKACA', 'PDE7A', 'CALM1', 'HRAS', 'KCNJ3']",0.7681788108764543,0,0,23
68,Metabolic reprogramming in colon cancer WP4290,0.09865432004169461,1.6952617500955292,3.9264521167985005,"['LDHA', 'PDHA1', 'PKM', 'MDH2', 'PGAM1', 'GOT2', 'PGK1', 'TALDO1', 'PYCR2', 'PDHB', 'TKT', 'GLS']",0.8000202025223155,0,0,12
69,Pathogenic Escherichia coli infection WP2272,0.09865432004169461,1.6952617500955292,3.9264521167985005,"['CDC42', 'TUBB2B', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ROCK1', 'NCK2', 'ABL1', 'PRKCA', 'FYN', 'ARPC4', 'ACTG1']",0.8000202025223155,0,0,12
70,Calcium Regulation in the Cardiac Cell WP536,0.10000252531528944,1.3491097688557272,3.106405973734747,"['RYR1', 'RYR2', 'CAMK2D', 'YWHAB', 'RGS16', 'CHRM5', 'ITPR1', 'ITPR2', 'ATP2A2', 'ADCY2', 'ADCY8', 'SLC8A1', 'YWHAQ', 'PRKACA', 'RGS7', 'KCNJ3', 'PRKCE', 'ATP2B3', 'PRKCA', 'ATP1B2', 'ATP1B1', 'ADCY9', 'PRKAR1A', 'GNB2', 'GNAQ', 'GNB1', 'CALM3', 'PRKD1', 'CALR', 'GNB5', 'CALM1']",0.8000202025223155,0,0,31
71,7q11.23 copy number variation syndrome WP4932,0.10336148136301436,1.4188655550129072,3.2201478790239046,"['ATP5PB', 'CLTC', 'UBE2E1', 'ATP5MC2', 'ATP5MC3', 'DDX21', 'UBE2L6', 'ACACB', 'ACACA', 'ATP5F1E', 'ATP5MC1', 'GRIP1', 'CLIP2', 'ATP5F1A', 'ATP5F1B', 'EIF4H', 'BUD23', 'SQSTM1', 'SF3B1', 'CLASP1', 'EIF2A', 'ATF4', 'FBN1']",0.8002077411794772,0,0,23
72,Constitutive Androstane Receptor Pathway WP2875,0.10431279483232472,2.25899097725251,5.106135671635597,"['SULT1A1', 'NCOA1', 'NCOA2', 'HSP90AA1', 'ABCB1', 'FOXO1']",0.8002077411794772,0,0,6
73,Type II interferon signaling (IFNG) WP619,0.10431279483232472,2.25899097725251,5.106135671635597,"['STAT1', 'IFNGR2', 'HLA-B', 'EIF2AK2', 'ISG15', 'IFIT2']",0.8002077411794772,0,0,6
74,Gastrin signaling pathway WP4659,0.10587693610962533,1.3906726096043918,3.1227245267653494,"['CDKN1B', 'ROCK1', 'SRC', 'PXN', 'FOXO1', 'CDC42', 'KAT5', 'FYN', 'RAC1', 'PRKACA', 'HRAS', 'MEF2D', 'MEF2C', 'MAP2K1', 'PRKCE', 'PRKCA', 'NFKB1', 'TJP1', 'PIK3CA', 'RPS6KB1', 'GNAQ', 'TCF4', 'PPARG', 'PRKD1', 'MAP3K11']",0.8012308678566241,0,0,25
75,TGF-beta Receptor Signaling WP560,0.11104122548440054,1.694996180290298,3.7253537040721825,"['TGFBR3', 'SMAD2', 'ZEB2', 'TGFB1', 'ZFYVE9', 'STAT1', 'SPP1', 'EP300', 'HRAS', 'RUNX2', 'NFKB1']",0.8291078169501908,0,0,11
76,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.1156992256612731,2.419969512195122,5.219296681703672,"['CD63', 'CD81', 'SPP1', 'SORBS2', 'SOD1']",0.8480726107064138,0,0,5
77,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.11705123614714158,1.6272678639663738,3.4907231206140743,"['TGFBR3', 'SMAD2', 'ZEB2', 'TGFB1', 'ZFYVE9', 'STAT1', 'SPP1', 'EP300', 'HRAS', 'RUNX2', 'NFKB1', 'FBN1']",0.8480726107064138,0,0,12
78,Vitamin D Receptor Pathway WP2877,0.12128355662733531,1.4534661049406357,3.0662670243385945,"['ABCB1', 'TGFB1', 'CDKN1B', 'GADD45A', 'IGFBP3', 'TPM1', 'CCNC', 'EFNA5', 'SLC8A1', 'FOXO1', 'SFRP1', 'CLMN', 'PNOC', 'CREG2', 'S100A6', 'TIMP2', 'SPP1', 'CLPTM1L']",0.8480726107064138,0,0,18
79,Ferroptosis WP4313,0.125290128220365,1.6947308132875143,3.5201646990783644,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'LPCAT3', 'VDAC3', 'VDAC2', 'SLC3A2', 'SAT2', 'ACSL3', 'FTL']",0.8480726107064138,0,0,10
80,AGE/RAGE pathway WP2324,0.12621640925992295,1.5311663479923519,3.1691427438741786,"['SMAD2', 'MAP2K1', 'ROCK1', 'SRC', 'STAT1', 'PRKCA', 'DDOST', 'TIRAP', 'FOXO1', 'NFKB1', 'SOD1', 'CDC42', 'CYCS', 'RAC1']",0.8480726107064138,0,0,14
81,Pyrimidine metabolism and related diseases WP4225,0.12717968999427104,2.709942857142857,5.5883203445565,"['NT5C', 'DPYD', 'TK2', 'UMPS']",0.8480726107064138,0,0,4
82,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.1323202397625497,6.772744575561477,13.698080682869167,"['PPARG', 'PPARA']",0.8480726107064138,0,0,2
83,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.1323202397625497,6.772744575561477,13.698080682869167,"['BAX', 'IL6ST']",0.8480726107064138,0,0,2
84,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.1323202397625497,6.772744575561477,13.698080682869167,"['NKRF', 'FYN']",0.8480726107064138,0,0,2
85,Tgif disruption of Shh signaling WP3674,0.1323202397625497,6.772744575561477,13.698080682869167,"['SMAD2', 'GLI3']",0.8480726107064138,0,0,2
86,Hippo-Yap signaling pathway WP4537,0.13606122783250874,2.032863133816241,4.054851039207803,"['LATS1', 'YWHAQ', 'TNIK', 'TEAD1', 'MAP4K3', 'MAP4K4']",0.8480726107064138,0,0,6
87,SARS-CoV-2 mitochondrial interactions WP5038,0.13606122783250874,2.032863133816241,4.054851039207803,"['TOMM70', 'NDUFB9', 'CTSL', 'DDX58', 'PHB', 'NFKB1']",0.8480726107064138,0,0,6
88,IL1 and megakaryocytes in obesity WP2865,0.1362973838635308,3.3869002284843868,6.7498081110234525,"['PIK3CA', 'TIMP2', 'NFKB1']",0.8480726107064138,0,0,3
89,Sulfation Biotransformation Reaction WP692,0.1362973838635308,3.3869002284843868,6.7498081110234525,"['SULT1A1', 'SULT4A1', 'PAPSS2']",0.8480726107064138,0,0,3
90,Transcriptional cascade regulating adipogenesis WP4211,0.1362973838635308,3.3869002284843868,6.7498081110234525,"['CEBPB', 'DDIT3', 'PPARG']",0.8480726107064138,0,0,3
91,Prion disease pathway WP3995,0.14178187243652823,1.6944656488549619,3.310080206321708,"['PDIA3', 'MEF2C', 'HSPA5', 'BCL11A', 'EP300', 'FYN', 'CHD2', 'NFKB1', 'HSP90B1']",0.8725038303786353,0,0,9
92,Acute viral myocarditis WP4298,0.14521652399951895,1.4831500956022945,2.8617816865157306,"['ENDOG', 'CXADR', 'TGFB1', 'SRC', 'STAT1', 'ILK', 'ABL1', 'CASP2', 'CYCS', 'BAX', 'DMD', 'FYN', 'EIF4G2', 'EIF4G1']",0.8839266678231589,0,0,14
93,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.1490241325910663,1.6138475245004456,3.0721960347083375,"['LATS1', 'MAPK10', 'ITGB5', 'YWHAQ', 'SRC', 'MAP4K5', 'TEAD1', 'MAP4K3', 'ACTG1', 'MAP4K4']",0.8973496156021197,0,0,10
94,Ebola Virus Pathway on Host WP4217,0.1578244178056181,1.3220729216800864,2.4409064070999693,"['DDX58', 'STAT1', 'CLTC', 'VPS4A', 'HLA-B', 'DAB2IP', 'HLA-C', 'EIF2AK2', 'CLTA', 'HLA-A', 'HLA-F', 'MERTK', 'NFKB1', 'ASGR1', 'IGF1R', 'ACTG1', 'CDC42', 'TIAM1', 'PIK3CA', 'CTSL', 'EP300', 'RAC1', 'CTSB']",0.940230574161129,0,0,23
95,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.16966616655113456,1.3907582403564034,2.4670973328760226,"['MAP2K1', 'CDKN1B', 'SRC', 'STAT1', 'PDE4D', 'ADCY2', 'BRAF', 'IGF1R', 'MYL12B', 'PIK3CA', 'RPS6KB1', 'APEX1', 'GNAQ', 'GNB1', 'PLCB1', 'HRAS']",0.981531024258709,0,0,16
96,Pathways Regulating Hippo Signaling WP4540,0.17322682899637976,1.329635725505227,2.331055383654324,"['SMAD2', 'NTRK2', 'PRKCE', 'PRKAG1', 'PRKCA', 'PRKAB1', 'IGF1R', 'LATS1', 'CDC42', 'PLCB4', 'CDH2', 'PRKAR1A', 'GNAQ', 'CDH13', 'RAC1', 'PRKACA', 'PLCB1', 'TEAD1', 'FGFR2', 'CDH18']",0.981531024258709,0,0,20
97,Aryl Hydrocarbon Receptor Netpath WP2586,0.1748478314526964,1.5403172619667465,2.68606564939378,"['HSP90AA1', 'MAP2K1', 'CDKN1B', 'SRC', 'CDC37', 'AIP', 'EP300', 'NCOA7', 'HRAS', 'NFKB1']",0.981531024258709,0,0,10
98,Computational Model of Aerobic Glycolysis WP4629,0.17527339718905519,2.258031746031746,3.932155121418914,"['LDHA', 'PKM', 'PGK1', 'PFKM']",0.981531024258709,0,0,4
99,Cysteine and methionine catabolism WP4504,0.17527339718905519,2.258031746031746,3.932155121418914,"['AHCY', 'GOT1', 'ETHE1', 'CDO1']",0.981531024258709,0,0,4
100,Glycolysis in senescence WP5049,0.17527339718905519,2.258031746031746,3.932155121418914,"['LDHA', 'PKM', 'PGK1', 'ALDOC']",0.981531024258709,0,0,4
101,Melatonin metabolism and effects WP3298,0.19211579923705507,1.5943622775321498,2.630150840220636,"['SULT1A1', 'CRY2', 'CRY1', 'PRKCA', 'APOE', 'CALM1', 'FOXO1', 'NFKB1']",0.9985648620835477,0,0,8
102,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.19211579923705507,1.5943622775321498,2.630150840220636,"['MAP2K1', 'PIK3CA', 'SRC', 'STAT1', 'STAT4', 'FYN', 'GAB2', 'NFKB1']",0.9985648620835477,0,0,8
103,Ciliary landscape WP4352,0.1960207580369655,1.1717726942041873,1.9094442856473104,"['ECHS1', 'IFT172', 'VPS4A', 'HTRA2', 'COPS7A', 'MYL6B', 'DCAF7', 'EHBP1', 'RPGR', 'PSMD8', 'PSMD7', 'PGRMC2', 'RMND5A', 'APMAP', 'BBS9', 'NUP88', 'SNRPB2', 'RAC1', 'DCAF11', 'CEP290', 'RNGTT', 'NDUFA5', 'EXOC6B', 'ACSL3', 'COX6C', 'DYNLL2', 'LSM4', 'NFKB1', 'AIMP1', 'COPS4', 'MKLN1', 'COPS6', 'PSMC6', 'MSH2', 'TBC1D4', 'RAB14', 'MFAP1', 'WNK1', 'WDR60', 'GID8', 'TIPRL', 'EXOC4', 'MCM4', 'CALM1', 'COPS8', 'EXOC2', 'PAFAH1B1', 'ARL8B']",0.9985648620835477,0,0,48
104,Imatinib and Chronic Myeloid Leukemia WP3640,0.1971625174395565,1.8817750677506775,3.0554888512928553,"['ABCB1', 'CDKN1B', 'GADD45A', 'ABL1', 'GAB2']",0.9985648620835477,0,0,5
105,Overview of interferons-mediated signaling pathway WP4558,0.1971625174395565,1.8817750677506775,3.0554888512928553,"['PIK3CA', 'STAT1', 'IFNGR2', 'PRKCA', 'IFNAR1']",0.9985648620835477,0,0,5
106,Vitamin B12 metabolism WP1533,0.1971625174395565,1.8817750677506775,3.0554888512928553,"['CUBN', 'MMAB', 'APOE', 'NFKB1', 'SOD1']",0.9985648620835477,0,0,5
107,Type 2 papillary renal cell carcinoma WP4241,0.19818799190545244,1.524675572519084,2.4677472495058574,"['EGLN1', 'SETD2', 'EGLN3', 'TGFB1', 'CADM2', 'EP300', 'ELOB', 'ELOC', 'VHL']",0.9985648620835477,0,0,9
108,15q13.3 copy number variation syndrome WP4942,0.19949331740481394,2.539889565879665,4.094237314434347,"['KAT2B', 'OTUD7A', 'FYN']",0.9985648620835477,0,0,3
109,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.19949331740481394,2.539889565879665,4.094237314434347,"['UBE2N', 'SQSTM1', 'NFKB1']",0.9985648620835477,0,0,3
110,p53 transcriptional gene network WP4963,0.20803896990704812,1.4021846547112382,2.2014717792439313,"['MSH2', 'SIVA1', 'XRCC5', 'MGMT', 'GADD45A', 'SESN1', 'SESN2', 'BAX', 'FANCC', 'ISG15', 'PRKAB1', 'RPRM']",0.9985648620835477,0,0,12
111,Senescence and Autophagy in Cancer WP615,0.21061462327434058,1.2880689655172415,2.0064575454571045,"['GABARAPL2', 'GABARAPL1', 'MAP2K1', 'CEBPB', 'SPARC', 'TGFB1', 'CDKN1B', 'SRC', 'IGFBP3', 'BRAF', 'CXCL14', 'GABARAP', 'IGF1R', 'RSL1D1', 'MAP1LC3B', 'MAP1LC3A', 'IL6ST', 'SQSTM1', 'HRAS']",0.9985648620835477,0,0,19
112,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.21071711050529196,1.6936713686618377,2.6374506910846374,"['RPS6KB1', 'SRC', 'PRKCA', 'PRKACA', 'SGK1', 'FOXO1']",0.9985648620835477,0,0,6
113,White fat cell differentiation WP4149,0.21071711050529196,1.6936713686618377,2.6374506910846374,"['CEBPB', 'DDIT3', 'RORA', 'PPARG', 'NR2F2', 'FOXO1']",0.9985648620835477,0,0,6
114,Metastatic brain tumor WP2249,0.22532103291865538,3.385991625428245,5.045903187342898,"['CDC42', 'CDK6']",0.9985648620835477,0,0,2
115,"Phase I biotransformations, non P450 WP136",0.22532103291865538,3.385991625428245,5.045903187342898,"['PON2', 'CES2']",0.9985648620835477,0,0,2
116,Arylamine metabolism WP694,0.22809276952200397,inf,inf,['SULT1A1'],0.9985648620835477,0,0,1
117,Codeine and Morphine Metabolism WP1604,0.22809276952200397,inf,inf,['ABCB1'],0.9985648620835477,0,0,1
118,TP53 network WP1742,0.22831776525775985,1.9352380952380952,2.8583793974750433,"['SUMO1', 'GADD45A', 'ABL1', 'BAX']",0.9985648620835477,0,0,4
119,Parkinson's disease pathway WP2371,0.22942993416084992,1.451908396946565,2.1374379721662744,"['PRKN', 'ATXN2', 'PINK1', 'SYT11', 'HTRA2', 'CASP2', 'CYCS', 'UBE2L6', 'PARK7']",0.9985648620835477,0,0,9
120,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.23368113466267676,1.3803299097416744,2.006720538143281,"['BEX3', 'CDKN1B', 'HSPA5', 'RPS6KB1', 'SERBP1', 'ABL1', 'RNF7', 'APOE', 'SQSTM1', 'NFKB1', 'HSPD1']",0.9985648620835477,0,0,11
121,RANKL/RANK signaling pathway WP2018,0.23368113466267676,1.3803299097416744,2.006720538143281,"['CDC42', 'MAP2K1', 'SRC', 'STAT1', 'MITF', 'TAB2', 'RAC1', 'GAB2', 'SQSTM1', 'PAPSS2', 'NFKB1']",0.9985648620835477,0,0,11
122,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.243587379769269,1.693407012195122,2.391564095986808,"['TJP1', 'PXN', 'ITPR1', 'LPP', 'MYLK']",0.9985648620835477,0,0,5
123,Striated Muscle Contraction Pathway WP383,0.243587379769269,1.693407012195122,2.391564095986808,"['TMOD1', 'MYOM1', 'TPM1', 'DMD', 'ACTG1']",0.9985648620835477,0,0,5
124,Sphingolipid pathway WP1422,0.25764952107208744,1.4818602212051868,2.0096322417065307,"['UGCG', 'ASAH1', 'CERS5', 'CERS6', 'SERINC1', 'SGPP2', 'PLPP1']",0.9985648620835477,0,0,7
125,Apoptosis Modulation and Signaling WP1772,0.2588626092375057,1.2706101759755164,1.7171760639497657,"['HRK', 'ENDOG', 'CRADD', 'HTRA2', 'PTPN13', 'NFKB1', 'TOLLIP', 'MADD', 'CASP2', 'CYCS', 'BAX', 'BIRC6', 'PRKD1', 'BCL2L2', 'MAP3K5']",0.9985648620835477,0,0,15
126,BDNF-TrkB Signaling WP3676,0.2607005110516996,1.4262133777786703,1.9173770162333947,"['NTRK2', 'MAP2K1', 'TRPC3', 'RPS6KB1', 'GAB1', 'BRAF', 'GAB2', 'HRAS']",0.9985648620835477,0,0,8
127,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.2607005110516996,1.4262133777786703,1.9173770162333947,"['MAP2K1', 'PLCB4', 'PIK3CA', 'PRKCE', 'PRKCA', 'PLCB1', 'HRAS', 'NFKB1']",0.9985648620835477,0,0,8
128,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.2623232151171707,1.3857564191533658,1.8543886011072879,"['RPTOR', 'SMAD2', 'MAP1LC3A', 'RPS6KB1', 'ILK', 'RICTOR', 'PRKAB1', 'NFKB1', 'IGF1R']",0.9985648620835477,0,0,9
129,Vitamin D-sensitive calcium signaling in depression WP4698,0.2623232151171707,1.3857564191533658,1.8543886011072879,"['GRM5', 'GPX4', 'ITPR1', 'KCNQ3', 'ITPR2', 'ATP2B3', 'GRIN2B', 'SLC8A1', 'PVALB']",0.9985648620835477,0,0,9
130,Interleukin-11 Signaling Pathway WP2332,0.2629698279327896,1.355021000381825,1.8099231981265043,"['ATF1', 'MAP2K1', 'TGFB1', 'RPS6KB1', 'SRC', 'STAT1', 'FYN', 'IL6ST', 'HRAS', 'RUNX2']",0.9985648620835477,0,0,10
131,Serotonin and anxiety-related events WP3944,0.26779804762048476,2.0316831683168317,2.676787547982989,"['PPP3CA', 'NLGN1', 'CRH']",0.9985648620835477,0,0,3
132,16p11.2 proximal deletion syndrome WP4949,0.28151849100411636,1.2320217096336499,1.5616579222655942,"['CCT3', 'CCT2', 'IGFBP3', 'KIF22', 'SEZ6L2', 'NFKB1', 'CCT6A', 'PPP4R4', 'TCP1', 'TMEM219', 'PPARG', 'CCT7', 'CDIPT', 'CCT5', 'CCT4', 'BPTF']",0.9985648620835477,0,0,16
133,Head and Neck Squamous Cell Carcinoma WP4674,0.2840591155545167,1.2394797245600613,1.5599756027358807,"['GAB1', 'NFKB1', 'IGF1R', 'RPTOR', 'CDK6', 'PIK3CA', 'SESN1', 'SESN2', 'AKT3', 'NUMB', 'FAT1', 'RICTOR', 'CSMD3', 'HRAS', 'FGFR2']",0.9985648620835477,0,0,15
134,miRNA targets in ECM and membrane receptors WP2911,0.2846270311501619,1.693142857142857,2.1275620327390024,"['ITGB5', 'COL4A2', 'COL4A1', 'COL5A2']",0.9985648620835477,0,0,4
135,Nanomaterial induced apoptosis WP2507,0.2846270311501619,1.693142857142857,2.1275620327390024,"['ENDOG', 'HTRA2', 'BAX', 'CYCS']",0.9985648620835477,0,0,4
136,Phytochemical activity on NRF2 transcriptional activation WP3,0.2846270311501619,1.693142857142857,2.1275620327390024,"['AIMP2', 'CEBPB', 'PIK3CA', 'PRKCA']",0.9985648620835477,0,0,4
137,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.2846270311501619,1.693142857142857,2.1275620327390024,"['LDHA', 'PDHA1', 'PIK3CA', 'SLC2A3']",0.9985648620835477,0,0,4
138,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.2846270311501619,1.693142857142857,2.1275620327390024,"['SMAD2', 'TGFB1', 'CDH2', 'RUNX2']",0.9985648620835477,0,0,4
139,Urea cycle and metabolism of amino groups WP497,0.2846270311501619,1.693142857142857,2.1275620327390024,"['ODC1', 'SMS', 'CKB', 'SRM']",0.9985648620835477,0,0,4
140,Rett syndrome causing genes WP4312,0.2889374259655969,1.258256880733945,1.562182706922248,"['MEF2C', 'KCNJ10', 'SATB2', 'STXBP1', 'BRAF', 'GRIN2B', 'XAB2', 'SCN8A', 'IMPDH2', 'TCF4', 'HIVEP2', 'HAP1', 'SCN1A']",0.9985648620835477,0,0,13
141,"Relationship between inflammation, COX-2 and EGFR WP4483",0.2924628987243591,1.5392876940133038,1.8924271705593996,"['PIK3CA', 'SRC', 'AKT3', 'BRAF', 'HRAS']",0.9985648620835477,0,0,5
142,Androgen receptor signaling pathway WP138,0.2928573352072733,1.1888671467860914,1.4600117192233386,"['NCOA1', 'NCOA2', 'ROCK1', 'SRC', 'DSTN', 'PARK7', 'PIAS2', 'RUNX2', 'FOXO1', 'CDC42', 'KAT2B', 'SUMO1', 'KAT5', 'RACK1', 'EP300', 'RAC1', 'CALR', 'FKBP4', 'PLPP1', 'RAN']",0.9985648620835477,0,0,20
143,Hepatitis B infection WP4666,0.2930273391403439,1.1593202175627313,1.4230532396258122,"['YWHAB', 'SRC', 'YWHAQ', 'AKT3', 'STAT4', 'EP300', 'HRAS', 'SMAD2', 'MAP2K1', 'TGFB1', 'ATP6AP1', 'DDX58', 'STAT1', 'PRKCA', 'BRAF', 'NFKB1', 'TIRAP', 'MAPK10', 'CREB3', 'PIK3CA', 'VDAC3', 'CYCS', 'BAX', 'TAB2', 'IFNAR1', 'ATF4']",0.9985648620835477,0,0,26
144,Estrogen signaling pathway WP712,0.2960933803948119,1.4513915364086922,1.7664601918381602,"['MAP2K1', 'PIK3CA', 'GNB1', 'BRAF', 'PRKACA', 'NFKB1']",0.9985648620835477,0,0,6
145,Genes controlling nephrogenesis WP4823,0.2960933803948119,1.4513915364086922,1.7664601918381602,"['NCK2', 'ILK', 'SLIT2', 'GLI3', 'FGFR2', 'CD2AP']",0.9985648620835477,0,0,6
146,NRF2-ARE regulation WP4357,0.2960933803948119,1.4513915364086922,1.7664601918381602,"['AIMP2', 'CEBPB', 'PIK3CA', 'SRC', 'PRKCA', 'FYN']",0.9985648620835477,0,0,6
147,Physiological and pathological hypertrophy of the heart WP1528,0.2960933803948119,1.4513915364086922,1.7664601918381602,"['PPP3CA', 'CAMK2D', 'PRKCE', 'RAC1', 'IL6ST', 'CALM1']",0.9985648620835477,0,0,6
148,Adipogenesis WP236,0.2961702889119635,1.192117212998439,1.4505928893259603,"['NCOA1', 'CNTFR', 'NCOA2', 'MEF2C', 'MBNL1', 'CEBPB', 'TGFB1', 'GADD45A', 'STAT1', 'CISD1', 'RORA', 'FOXO1', 'BSCL2', 'DDIT3', 'NDN', 'PPARG', 'IL6ST', 'PPARA', 'MEF2D']",0.9985648620835477,0,0,19
149,Disruption of postsynaptic signaling by CNV WP4875,0.29655270933837635,1.3253567872552274,1.611011339243106,"['TJP1', 'RYR2', 'NLGN1', 'CAMK2D', 'DLG2', 'NRXN1', 'NRXN3', 'DLGAP1', 'GRIN2B']",0.9985648620835477,0,0,9
150,Allograft Rejection WP2328,0.297439424098757,1.3945349306770762,1.6909359268908426,"['ABCB1', 'TGFB1', 'STAT1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F']",0.9985648620835477,0,0,7
151,Lipid Metabolism Pathway WP3965,0.297439424098757,1.3945349306770762,1.6909359268908426,"['PDHA1', 'PRKAR1A', 'AKT3', 'PRKAG1', 'PRKACA', 'PRKAB1', 'ACACA']",0.9985648620835477,0,0,7
152,Leptin signaling pathway WP2034,0.3029714020113512,1.1998548366513528,1.4327668908713316,"['NCOA1', 'MAP2K1', 'ROCK1', 'SRC', 'STAT1', 'ACACB', 'FOXO1', 'ACACA', 'NFKB1', 'CDC42', 'RPS6KB1', 'CFL2', 'LEPR', 'BAX', 'FYN', 'RAC1', 'HRAS']",0.9985648620835477,0,0,17
153,Nuclear Receptors Meta-Pathway WP2882,0.30730177319290086,1.1117527047913447,1.3117848542578745,"['ABCB1', 'CDKN1B', 'HSP90AB1', 'SRXN1', 'SRC', 'MGST3', 'ABHD2', 'SLC2A3', 'TXN', 'SLC6A1', 'SLC5A3', 'FOXO1', 'SULT1A1', 'AKAP13', 'EPB41L4B', 'SLC39A6', 'EP300', 'SLC39A7', 'NCOA1', 'GSTM3', 'NCOA2', 'HSP90AA1', 'TGFB1', 'SLC2A13', 'SLC39A11', 'AIP', 'CES4A', 'TGFBR3', 'SLC7A5', 'KAT2B', 'PSMC5', 'NAV3', 'ACOX1', 'CDC37', 'CDC42EP3', 'BAX', 'PPARA', 'SQSTM1', 'CES2', 'FKBP5', 'FTL']",0.9985648620835477,0,0,41
154,Dopaminergic Neurogenesis WP2855,0.3210500409104307,2.2570739753838347,2.564393279644868,"['SOX2', 'TGFB1']",0.9985648620835477,0,0,2
155,Peroxiredoxin 2 induced ovarian failure WP4873,0.3210500409104307,2.2570739753838347,2.564393279644868,"['MAPK10', 'BAX']",0.9985648620835477,0,0,2
156,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.3210500409104307,2.2570739753838347,2.564393279644868,"['FOXO1', 'IGF1R']",0.9985648620835477,0,0,2
157,Vitamin B12 Disorders WP4271,0.3210500409104307,2.2570739753838347,2.564393279644868,"['CUBN', 'MMAB']",0.9985648620835477,0,0,2
158,Pancreatic adenocarcinoma pathway WP4263,0.32330907926757646,1.1726276404560587,1.3240684095574047,"['SMAD2', 'RALBP1', 'MAP2K1', 'TGFB1', 'STAT1', 'GADD45A', 'PEBP1', 'BRAF', 'NFKB1', 'CDC42', 'MAPK10', 'TIAM1', 'CDK6', 'PIK3CA', 'RPS6KB1', 'AKT3', 'BAX', 'RAC1']",0.9985648620835477,0,0,18
159,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.32455116926964456,1.2418767507002801,1.3974988954853966,"['SMAD2', 'MAP2K1', 'TGFB1', 'ADCY9', 'ADCY2', 'BANF1', 'ADCY8', 'HRAS', 'EMD', 'SYNE1', 'PLEC']",0.9985648620835477,0,0,11
160,Common Pathways Underlying Drug Addiction WP2636,0.3282032534039616,1.2543662410023617,1.3975172603582193,"['GRIA1', 'GRM5', 'MAP2K1', 'PRKCA', 'ADCY8', 'PRKACA', 'CALM1', 'GRIA3', 'ACTG1', 'GRIA4']",0.9985648620835477,0,0,10
161,IL-3 signaling pathway WP286,0.33178878083974683,1.2699904580152672,1.4011255005602838,"['MAP2K1', 'TGFB1', 'YWHAQ', 'YWHAB', 'SRC', 'FYN', 'GAB2', 'PRKACA', 'HRAS']",0.9985648620835477,0,0,9
162,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.338107213238958,1.692878903274943,1.8357447372768307,"['SFRP1', 'SST', 'FOXO1']",0.9985648620835477,0,0,3
163,Development and heterogeneity of the ILC family WP3893,0.338107213238958,1.692878903274943,1.8357447372768307,"['ID2', 'RORA', 'TOX']",0.9985648620835477,0,0,3
164,Genes targeted by miRNAs in adipocytes WP1992,0.338107213238958,1.692878903274943,1.8357447372768307,"['TMSB4X', 'PTBP2', 'KCNJ2']",0.9985648620835477,0,0,3
165,Major receptors targeted by epinephrine and norepinephrine WP4589,0.338107213238958,1.692878903274943,1.8357447372768307,"['ADCY9', 'ADCY2', 'ADCY8']",0.9985648620835477,0,0,3
166,miRNAs involved in DNA damage response WP1545,0.338107213238958,1.692878903274943,1.8357447372768307,"['CDKN1B', 'CDK6', 'ABL1']",0.9985648620835477,0,0,3
167,Non-homologous end joining WP438,0.338107213238958,1.692878903274943,1.8357447372768307,"['XRCC6', 'DCLRE1C', 'XRCC5']",0.9985648620835477,0,0,3
168,TCA cycle in senescence WP5050,0.338107213238958,1.692878903274943,1.8357447372768307,"['PDHA1', 'GOT1', 'BRAF']",0.9985648620835477,0,0,3
169,Ras signaling WP4223,0.33870144162942134,1.1070649437825137,1.198548653420916,"['RAB5B', 'RAB5C', 'RASGRF2', 'RASAL2', 'IGF1R', 'CDC42', 'GNG10', 'AKT3', 'ABL1', 'RAC1', 'PRKACA', 'HRAS', 'NTRK2', 'RALBP1', 'MAP2K1', 'PLA2G4C', 'GAB1', 'PRKCA', 'KSR2', 'GAB2', 'GRIN2B', 'NFKB1', 'MAPK10', 'TIAM1', 'AFDN', 'PIK3CA', 'GNB2', 'GNB1', 'CALM3', 'GNB5', 'CALM1', 'FGFR2', 'EXOC2']",0.9985648620835477,0,0,33
170,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.3410609067667597,1.3544796035074342,1.4570058608642382,"['RAB3A', 'HSPB8', 'MFN2', 'SBF2', 'RAB11A', 'DNM2']",0.9985648620835477,0,0,6
171,Apoptosis Modulation by HSP70 WP384,0.342589292676448,1.5048465608465609,1.6120261672625575,"['MAPK10', 'CASP2', 'CYCS', 'NFKB1']",0.9985648620835477,0,0,4
172,Globo Sphingolipid Metabolism WP1424,0.342589292676448,1.5048465608465609,1.6120261672625575,"['B3GALNT1', 'ST8SIA1', 'GALNT2', 'ST6GALNAC5']",0.9985648620835477,0,0,4
173,Nicotine Activity on Dopaminergic Neurons WP1602,0.342589292676448,1.5048465608465609,1.6120261672625575,"['CHRNA4', 'GNB1', 'ADCY2', 'PRKACA']",0.9985648620835477,0,0,4
174,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.342589292676448,1.5048465608465609,1.6120261672625575,"['OMG', 'PLP1', 'SOX6', 'SOX5']",0.9985648620835477,0,0,4
175,Oxidative Stress WP408,0.34277368903355243,1.4108549288617886,1.5105809955030993,"['MAPK10', 'NFIX', 'NFKB1', 'TXN2', 'SOD1']",0.9985648620835477,0,0,5
176,Toll-like Receptor Signaling Pathway WP75,0.34613607718276335,1.1899743780477725,1.262471537631313,"['MAP2K1', 'STAT1', 'NFKB1', 'TIRAP', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'SPP1', 'TAB2', 'RAC1', 'IFNAR1', 'NFKBIB']",0.9985648620835477,0,0,13
177,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.351201690802966,1.1953067050282091,1.2507624849200507,"['SCARB2', 'CDKN1B', 'TGFB1', 'YWHAQ', 'CDH2', 'CTSL', 'FAT1', 'ILK', 'MYH9', 'FYN', 'PARVA', 'CD2AP']",0.9985648620835477,0,0,12
178,TNF-alpha signaling pathway WP231,0.3526663140336558,1.1516003062787137,1.2002357903496184,"['HSP90AA1', 'OTUD7B', 'KSR2', 'TXN', 'NFKB1', 'PSMD2', 'CDC37', 'MADD', 'BAX', 'TAB2', 'RAC1', 'BTRC', 'GLUL', 'HRAS', 'MAP3K5', 'SKP1', 'NFKBIB']",0.9985648620835477,0,0,17
179,Phosphodiesterases in neuronal function WP4222,0.3564700809905985,1.2016806722689075,1.2395395821207835,"['GRIA1', 'GUCY1A2', 'ADCY9', 'PDE10A', 'PDE4D', 'PDE5A', 'ADCY2', 'PDE6B', 'ADCY8', 'PDE7A', 'GRIN2B']",0.9985648620835477,0,0,11
180,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.3693900446773241,1.1564053537284895,1.1516665914181379,"['PRKN', 'HSPA9', 'HSPA5', 'HSPA4', 'UBE2L6', 'PSMD8', 'TUBB2B', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMC6', 'PSMD2', 'PSMC1']",0.9985648620835477,0,0,14
181,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3709990124785502,1.0927279722970373,1.0835008441622176,"['GRIA1', 'RAB3A', 'DOCK3', 'SRC', 'YBX1', 'ACACB', 'CDC42', 'GRIP1', 'CDH2', 'DPYSL2', 'NCK2', 'RACK1', 'SPP1', 'KCNN2', 'FYN', 'RAC1', 'HRAS', 'GRIA3', 'NTRK2', 'MEF2C', 'MAP2K1', 'STAT1', 'EIF2S2', 'GRIN2B', 'NFKB1', 'MAPK10', 'TIAM1', 'RPS6KB1', 'MAPT', 'SQSTM1']",0.9985648620835477,0,0,30
182,IL-2 signaling pathway WP49,0.3737036271763434,1.2313135167007734,1.2119723350871823,"['MAP2K1', 'CCND2', 'RPS6KB1', 'STAT1', 'FYN', 'GAB2', 'MAPT', 'HRAS']",0.9985648620835477,0,0,8
183,Neural Crest Cell Migration in Cancer WP4565,0.3737036271763434,1.2313135167007734,1.2119723350871823,"['NTRK2', 'TIAM1', 'ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1', 'EPHB1']",0.9985648620835477,0,0,8
184,Complement system WP2806,0.38000557820625547,1.247460757156048,1.2070047900590375,"['RPS19', 'SPP1', 'PRKCA', 'CD59', 'TXN', 'CALR', 'PRKACA']",0.9985648620835477,0,0,7
185,TGF-beta Signaling Pathway WP366,0.3832382103731894,1.0984696788919437,1.053540647617038,"['SMAD2', 'MEF2C', 'MAP2K1', 'TGFB1', 'SMURF2', 'ROCK1', 'ZFYVE9', 'SMURF1', 'SRC', 'WWP1', 'PIAS2', 'RUNX2', 'PJA1', 'TGFBR3', 'CDC42', 'ZEB2', 'ZFYVE16', 'ZEB1', 'SUMO1', 'EP300', 'STRAP', 'RAC1', 'BTRC', 'SKP1']",0.9985648620835477,0,0,24
186,Resistin as a regulator of inflammation WP4481,0.3866249730936678,1.2696816622188334,1.206578632882709,"['PLCB4', 'PIK3CA', 'AKT3', 'ITPR1', 'PLCB1', 'NFKB1']",0.9985648620835477,0,0,6
187,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.39356466615508995,1.3021810506566605,1.2142967067207315,"['LATS1', 'YWHAQ', 'RAC1', 'TEAD1', 'FOXO1']",0.9985648620835477,0,0,5
188,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.39356466615508995,1.3021810506566605,1.2142967067207315,"['PPP3CA', 'FYN', 'PRKCA', 'CALM1', 'NFKB1']",0.9985648620835477,0,0,5
189,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.39356466615508995,1.3021810506566605,1.2142967067207315,"['ADAMTS2', 'CRTAP', 'ITPR1', 'PLOD2', 'PPIB']",0.9985648620835477,0,0,5
190,Transcription co-factors SKI and SKIL protein partners WP4533,0.40075998487101155,1.3542095238095238,1.2382791299659819,"['LATS1', 'SATB2', 'MERTK', 'TEAD1']",0.9985648620835477,0,0,4
191,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.40075998487101155,1.3542095238095238,1.2382791299659819,"['STAT1', 'DDX58', 'EIF2AK2', 'IFNAR1']",0.9985648620835477,0,0,4
192,Composition of Lipid Particles WP3601,0.40417447159772746,3.385083713850837,3.0665765627008827,['APOE'],0.9985648620835477,0,0,1
193,Drug Induction of Bile Acid Pathway WP2289,0.40417447159772746,3.385083713850837,3.0665765627008827,['ABCB1'],0.9985648620835477,0,0,1
194,let-7 inhibition of ES cell reprogramming WP3299,0.40417447159772746,3.385083713850837,3.0665765627008827,['SOX2'],0.9985648620835477,0,0,1
195,Metabolism of alpha-linolenic acid WP4586,0.40417447159772746,3.385083713850837,3.0665765627008827,['FADS1'],0.9985648620835477,0,0,1
196,"GPCRs, Class B Secretin-like WP334",0.40789311126997635,1.4508758568164508,1.3010731002761655,"['ADCYAP1R1', 'ADGRL2', 'ADGRL3']",0.9985648620835477,0,0,3
197,Hedgehog Signaling Pathway Netpath WP47,0.40789311126997635,1.4508758568164508,1.3010731002761655,"['STK36', 'SAP18', 'GLI3']",0.9985648620835477,0,0,3
198,"NAD metabolism, sirtuins and aging WP3630",0.40789311126997635,1.4508758568164508,1.3010731002761655,"['PPARG', 'NFKB1', 'FOXO1']",0.9985648620835477,0,0,3
199,Osteopontin Signaling WP1434,0.40789311126997635,1.4508758568164508,1.3010731002761655,"['MAP2K1', 'SPP1', 'NFKB1']",0.9985648620835477,0,0,3
200,Integrated Cancer Pathway WP1971,0.41244462851073554,1.177645439012657,1.0429855882880454,"['ATF1', 'SMAD2', 'CDKN1B', 'POU2F1', 'MSH2', 'STAT1', 'BAX', 'MAP3K5']",0.9985648620835477,0,0,8
201,p38 MAPK Signaling Pathway WP400,0.41244462851073554,1.177645439012657,1.0429855882880454,"['CDC42', 'STAT1', 'DDIT3', 'RAC1', 'HRAS', 'MEF2D', 'HMGN1', 'MAP3K5']",0.9985648620835477,0,0,8
202,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.41244462851073554,1.177645439012657,1.0429855882880454,"['TGFB1', 'DDX58', 'STAT1', 'EP300', 'TRIM25', 'NFKB1', 'IFIT2', 'IFNAR1']",0.9985648620835477,0,0,8
203,3q29 copy number variation syndrome WP4906,0.4129790108646538,1.1286460323525664,0.9981277217545653,"['DYNC2H1', 'GRIA1', 'DYNC2LI1', 'TGFB1', 'NCBP2', 'WDR60', 'CEP350', 'PXN', 'UBE2N', 'PIGZ', 'MELTF', 'DYNLL2']",0.9985648620835477,0,0,12
204,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.4134263356239934,1.6926151503616291,1.4950462190691096,"['SRC', 'VHL']",0.9985648620835477,0,0,2
205,Aspirin and miRNAs WP4707,0.4134263356239934,1.6926151503616291,1.4950462190691096,"['PPARA', 'NFKB1']",0.9985648620835477,0,0,2
206,Biogenic Amine Synthesis WP550,0.4134263356239934,1.6926151503616291,1.4950462190691096,"['GAD1', 'GAD2']",0.9985648620835477,0,0,2
207,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4134263356239934,1.6926151503616291,1.4950462190691096,"['TBC1D4', 'RPS6KB1']",0.9985648620835477,0,0,2
208,Insulin signaling in adipocytes (normal condition) WP3634,0.4134263356239934,1.6926151503616291,1.4950462190691096,"['TBC1D4', 'RPS6KB1']",0.9985648620835477,0,0,2
209,LDLRAD4 and what we know about it WP4904,0.4134263356239934,1.6926151503616291,1.4950462190691096,"['SMAD2', 'LDLRAD4']",0.9985648620835477,0,0,2
210,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4134263356239934,1.6926151503616291,1.4950462190691096,"['AHCY', 'CDO1']",0.9985648620835477,0,0,2
211,Selective expression of chemokine receptors during T-cell polarization WP4494,0.4134263356239934,1.6926151503616291,1.4950462190691096,"['TGFB1', 'IFNGR2']",0.9985648620835477,0,0,2
212,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.4134263356239934,1.6926151503616291,1.4950462190691096,"['UBE2N', 'NFKB1']",0.9985648620835477,0,0,2
213,Interferon type I signaling pathways WP585,0.4213488805506317,1.1285968933027757,0.9754396289179127,"['RPTOR', 'EIF4A1', 'RPS6KB1', 'STAT1', 'RACK1', 'STAT4', 'FYN', 'RAC1', 'GAB2', 'EIF4B', 'IFNAR1']",0.9985648620835477,0,0,11
214,Kit receptor signaling pathway WP304,0.4213488805506317,1.1285968933027757,0.9754396289179127,"['MAP2K1', 'RPS6KB1', 'SRC', 'STAT1', 'EP300', 'PRKCA', 'MITF', 'FYN', 'GAB2', 'MAPT', 'HRAS']",0.9985648620835477,0,0,11
215,miRNA regulation of prostate cancer signaling pathways WP3981,0.4217623383061629,1.184954233409611,1.022986753101849,"['MAP2K1', 'CDKN1B', 'PIK3CA', 'AKT3', 'PLCL2', 'FOXO1', 'NFKB1']",0.9985648620835477,0,0,7
216,Neural Crest Cell Migration during Development WP4564,0.4217623383061629,1.184954233409611,1.022986753101849,"['TIAM1', 'ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1', 'EPHB1']",0.9985648620835477,0,0,7
217,Prolactin Signaling Pathway WP2037,0.42643129722372125,1.1023700475788163,0.9395544121454319,"['MAP2K1', 'SRC', 'STAT1', 'PXN', 'GAB2', 'NFKB1', 'PIK3CA', 'RPS6KB1', 'RPS6KA2', 'FYN', 'RAC1', 'PPIB', 'HRAS', 'NFKBIB']",0.9985648620835477,0,0,14
218,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4321457051596388,1.1948599493171268,1.002478496766943,"['SMAD2', 'TGFB1', 'PIK3CA', 'BAX', 'BRAF', 'MAP3K5']",0.9985648620835477,0,0,6
219,DNA Mismatch Repair WP531,0.44397734046208315,1.209032012195122,0.9817119325109959,"['POLE4', 'MSH2', 'RPA3', 'POLD2', 'RPA2']",0.9985648620835477,0,0,5
220,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.44397734046208315,1.209032012195122,0.9817119325109959,"['NDUFA13', 'HSP90AA1', 'COPS6', 'RAC1', 'AAMP']",0.9985648620835477,0,0,5
221,Unfolded protein response WP4925,0.44397734046208315,1.209032012195122,0.9817119325109959,"['XBP1', 'HSPA5', 'DDIT3', 'CASP2', 'ATF4']",0.9985648620835477,0,0,5
222,Amino Acid metabolism WP3925,0.4460442177523114,1.0805157173322046,0.8723405218299947,"['WARS', 'PDHA1', 'PPM1L', 'GOT1', 'MDH2', 'ODC1', 'GOT2', 'GLS', 'SRM', 'LDHA', 'PKM', 'SMS', 'IARS', 'BCAT1', 'GLUL']",0.9985648620835477,0,0,15
223,Nephrotic syndrome WP4758,0.45107525438511104,1.1284497011318835,0.8983826085972709,"['SCARB2', 'YARS', 'CUBN', 'ANLN', 'PDSS2', 'MYH9', 'WDR73', 'CD2AP']",0.9985648620835477,0,0,8
224,One-carbon metabolism WP241,0.457913635996956,1.230961038961039,0.9614725000191011,"['AHCYL2', 'AHCY', 'AMT', 'GLRX']",0.9985648620835477,0,0,4
225,"GPCRs, Other WP117",0.46320784076597027,1.1284007119247395,0.8683939715930734,"['EDNRA', 'ADGRV1', 'CELSR2', 'CELSR3', 'ADGRL2', 'GPR135', 'ADGRL3']",0.9985648620835477,0,0,7
226,DNA damage response WP707,0.46452400402392374,1.0920198549064528,0.8372975366658761,"['CDKN1B', 'CCND2', 'CDK6', 'GADD45A', 'SESN1', 'ABL1', 'TLK1', 'RPA2', 'CYCS', 'BAX']",0.9985648620835477,0,0,10
227,Melanoma WP4685,0.4646335683402844,1.073394495412844,0.8227635455739084,"['MAP2K1', 'GADD45A', 'MITF', 'BRAF', 'CDK6', 'PIK3CA', 'ERBB4', 'AKT3', 'BAX', 'CALM3', 'RAC1', 'CALM1', 'HRAS']",0.9985648620835477,0,0,13
228,NRF2 pathway WP2884,0.47215582639057574,1.0506081696800011,0.7884249162138737,"['GSTM3', 'HSP90AA1', 'TGFB1', 'HSP90AB1', 'SRXN1', 'MGST3', 'SLC2A13', 'SLC39A11', 'SLC2A3', 'TXN', 'SLC6A1', 'SLC5A3', 'CES4A', 'SLC39A6', 'SLC39A7', 'SQSTM1', 'CES2', 'FTL']",0.9985648620835477,0,0,18
229,Oncostatin M Signaling Pathway WP2374,0.4749521216101012,1.0690022725901493,0.7959163167633309,"['MAP2K1', 'CEBPB', 'CDKN1B', 'SRC', 'STAT1', 'PRKCE', 'PXN', 'PRKCA', 'RICTOR', 'IL6ST', 'HRAS', 'NFKB1']",0.9985648620835477,0,0,12
230,Regulatory circuits of the STAT3 signaling pathway WP4538,0.4749521216101012,1.0690022725901493,0.7959163167633309,"['GHR', 'RPTOR', 'PTPRD', 'MAPK10', 'CNTFR', 'SRC', 'IFNGR2', 'STMN1', 'RICTOR', 'IL6ST', 'MAPK6', 'IFNAR1']",0.9985648620835477,0,0,12
231,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.47523383517959245,1.2693735719725818,0.9443483255205372,"['ZEB1', 'IL6ST', 'NFKB1']",0.9985648620835477,0,0,3
232,Overview of nanoparticle effects WP3287,0.47523383517959245,1.2693735719725818,0.9443483255205372,"['COL4A1', 'AKT3', 'BAX']",0.9985648620835477,0,0,3
233,The influence of laminopathies on Wnt signaling WP4844,0.4770477800308457,1.1283517600711652,0.8351367205885505,"['CEBPB', 'CDK6', 'SPP1', 'PPARG', 'EMD', 'RUNX2']",0.9985648620835477,0,0,6
234,Chemokine signaling pathway WP3929,0.47722276771308697,1.0381478639038118,0.7679925958005571,"['MAP2K1', 'ROCK1', 'STAT1', 'PXN', 'BRAF', 'ADCY2', 'ADCY8', 'CXCL14', 'NFKB1', 'CDC42', 'TIAM1', 'GNG10', 'ADCY9', 'PLCB4', 'PIK3CA', 'GNB2', 'AKT3', 'GNB1', 'GNB5', 'RAC1', 'PLCB1', 'HRAS', 'NFKBIB']",0.9985648620835477,0,0,23
235,Alzheimer's disease WP2059,0.48348797484242745,1.0531378797535584,0.7653456649302292,"['ATP5MD', 'ITPR1', 'ATP2A2', 'ITPR2', 'GRIN2B', 'PPP3CA', 'PLCB4', 'GNAQ', 'CYCS', 'CALM3', 'MAPT', 'APOE', 'PLCB1', 'CALM1']",0.9985648620835477,0,0,14
236,G13 Signaling Pathway WP524,0.48924690996116926,1.083189622281572,0.7743592503395673,"['CDC42', 'MAPK10', 'ROCK1', 'RPS6KB1', 'PIK3CA', 'CFL2', 'RAC1', 'CALM1']",0.9985648620835477,0,0,8
237,Cardiac Progenitor Differentiation WP2406,0.49327197116986354,1.1283028455284554,0.7973655183872231,"['SOX2', 'MESP1', 'MEF2C', 'TGFB1', 'THY1']",0.9985648620835477,0,0,5
238,Glycosylation and related congenital defects WP4521,0.49327197116986354,1.1283028455284554,0.7973655183872231,"['DPM2', 'DPM3', 'MPI', 'MOGS', 'MAGT1']",0.9985648620835477,0,0,5
239,Energy Metabolism WP1541,0.49829084095535525,1.057774914089347,0.73681570460725,"['NCOA1', 'PPP3CA', 'MEF2C', 'PRKAG1', 'EP300', 'PPARG', 'PPARA', 'MEF2D', 'PRKAB1', 'FOXO1']",0.9985648620835477,0,0,10
240,Cancer immunotherapy by PD-1 blockade WP4585,0.49899949737654165,1.353939855348306,0.9411915483608511,"['HLA-A', 'NFKB1']",0.9985648620835477,0,0,2
241,Cell Differentiation - Index WP2029,0.49899949737654165,1.353939855348306,0.9411915483608511,"['MEF2C', 'MEF2D']",0.9985648620835477,0,0,2
242,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.49899949737654165,1.353939855348306,0.9411915483608511,"['EBP', 'DHCR24']",0.9985648620835477,0,0,2
243,Dual hijack model of Vif in HIV infection WP3300,0.49899949737654165,1.353939855348306,0.9411915483608511,"['ELOB', 'ELOC']",0.9985648620835477,0,0,2
244,HIF1A and PPARG regulation of glycolysis WP2456,0.49899949737654165,1.353939855348306,0.9411915483608511,"['LDHA', 'PPARG']",0.9985648620835477,0,0,2
245,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.49899949737654165,1.353939855348306,0.9411915483608511,"['TGFB1', 'NFKB1']",0.9985648620835477,0,0,2
246,Pentose Phosphate Metabolism WP134,0.49899949737654165,1.353939855348306,0.9411915483608511,"['TALDO1', 'TKT']",0.9985648620835477,0,0,2
247,Thiamine metabolic pathways WP4297,0.49899949737654165,1.353939855348306,0.9411915483608511,"['PDHA1', 'TKT']",0.9985648620835477,0,0,2
248,Hedgehog Signaling Pathway WP4249,0.5039278378461761,1.0769884196657653,0.7380840731813049,"['CCND2', 'SMURF2', 'SMURF1', 'HHIP', 'FBXL17', 'PRKACA', 'GLI3']",0.9985648620835477,0,0,7
249,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5130638534864824,1.1282539682539683,0.7529458940654251,"['CCND2', 'NFKB1', 'RUNX2', 'FGFR2']",0.9985648620835477,0,0,4
250,Immune response to tuberculosis WP4197,0.5130638534864824,1.1282539682539683,0.7529458940654251,"['STAT1', 'IFNGR2', 'IFIT3', 'IFNAR1']",0.9985648620835477,0,0,4
251,Nucleotide metabolism WP404,0.5130638534864824,1.1282539682539683,0.7529458940654251,"['PRPS1', 'NME2', 'OAZ1', 'SRM']",0.9985648620835477,0,0,4
252,Pre-implantation embryo WP3527,0.5130638534864824,1.1282539682539683,0.7529458940654251,"['SOX2', 'DDIT3', 'ATP1A1', 'NR3C2']",0.9985648620835477,0,0,4
253,Prostaglandin Synthesis and Regulation WP98,0.5130638534864824,1.1282539682539683,0.7529458940654251,"['EDNRA', 'S100A6', 'MITF', 'PPARG']",0.9985648620835477,0,0,4
254,Proteoglycan biosynthesis WP4784,0.5130638534864824,1.1282539682539683,0.7529458940654251,"['B3GAT3', 'IMPAD1', 'B4GALT7', 'PAPSS2']",0.9985648620835477,0,0,4
255,Signal Transduction of S1P Receptor WP26,0.5130638534864824,1.1282539682539683,0.7529458940654251,"['ASAH1', 'AKT3', 'MAPK6', 'PLCB1']",0.9985648620835477,0,0,4
256,PI3K-Akt signaling pathway WP4172,0.5205172826497857,1.0036429581033148,0.6553107921437579,"['CDKN1B', 'HSP90AB1', 'ITGB5', 'EFNA5', 'IGF1R', 'HSP90B1', 'RPTOR', 'GHR', 'GNG10', 'RELN', 'CCND2', 'PPP2R5E', 'AKT3', 'SPP1', 'RAC1', 'HRAS', 'EIF4B', 'NTRK2', 'MAP2K1', 'HSP90AA1', 'PPP2R5B', 'PRKCA', 'VEGFD', 'NFKB1', 'CREB3', 'CDK6', 'FGF14', 'COL4A2', 'PIK3CA', 'RPS6KB1', 'COL4A1', 'PPP2R2B', 'CDC37', 'GNB2', 'GNB1', 'PPP2R2D', 'GNB5', 'SGK1', 'EIF4E2', 'FGF12', 'FGFR2', 'ATF4', 'IFNAR1']",0.9985648620835477,0,0,43
257,Bladder cancer WP2828,0.5208317086474467,1.0688444328510947,0.6972374776622907,"['MAP2K1', 'SRC', 'DAPK1', 'DAPK2', 'BRAF', 'HRAS']",0.9985648620835477,0,0,6
258,Oxidative Damage WP3941,0.5208317086474467,1.0688444328510947,0.6972374776622907,"['CDC42', 'MAPK10', 'CDKN1B', 'GADD45A', 'CYCS', 'NFKB1']",0.9985648620835477,0,0,6
259,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5208317086474467,1.0688444328510947,0.6972374776622907,"['RPTOR', 'CDKN1B', 'PIK3CA', 'RICTOR', 'HRAS', 'FOXO1']",0.9985648620835477,0,0,6
260,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5232215942044488,1.023238034279212,0.6628026478641833,"['SMAD2', 'MAP2K1', 'TGFB1', 'DCC', 'GADD45A', 'BRAF', 'MAPK10', 'MSH2', 'AKT3', 'CYCS', 'BAX', 'RAC1', 'EXOC2']",0.9985648620835477,0,0,13
261,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5260025573127332,1.0102801439334566,0.6490536747365949,"['SMAD2', 'MAP2K1', 'SPARC', 'TGFB1', 'PDCD6', 'EIF5A2', 'TJP1', 'ZEB2', 'ZEB1', 'FMNL2', 'CDH2', 'COL4A2', 'PIK3CA', 'RBBP4', 'COL4A1', 'ID2', 'AKT3', 'STRAP', 'HRAS', 'MEF2D']",0.9985648620835477,0,0,20
262,miRNA regulation of DNA damage response WP1530,0.531465867096135,1.0256054242308539,0.6483019093201635,"['CDKN1B', 'CCND2', 'CDK6', 'GADD45A', 'SESN1', 'ABL1', 'TLK1', 'RPA2', 'CYCS', 'BAX']",0.9985648620835477,0,0,10
263,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.5387693995548015,1.1282051282051282,0.6977583515219368,"['ABCB1', 'PPARG', 'PPARA']",0.9985648620835477,0,0,3
264,Omega-3/Omega-6 FA synthesis WP4723,0.5387693995548015,1.1282051282051282,0.6977583515219368,"['ACOX1', 'ACSL3', 'FADS1']",0.9985648620835477,0,0,3
265,SARS coronavirus and innate immunity WP4912,0.5387693995548015,1.1282051282051282,0.6977583515219368,"['STAT1', 'DDX58', 'IFNAR1']",0.9985648620835477,0,0,3
266,MECP2 and Associated Rett Syndrome WP3584,0.5394287601399038,1.0080956836581099,0.6222415675605674,"['GRIA1', 'MEF2C', 'RBFOX1', 'PRPF38A', 'GRID1', 'GAD1', 'YBX1', 'IGF1R', 'FUT8', 'SST', 'SGK1', 'GRIA3', 'FKBP5', 'GRIA4']",0.9985648620835477,0,0,14
267,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.5401014778225133,1.692351598173516,1.0424855977880452,['NFKB1'],0.9985648620835477,0,0,1
268,Estrogen metabolism WP697,0.5401014778225133,1.692351598173516,1.0424855977880452,['SULT1A1'],0.9985648620835477,0,0,1
269,FTO Obesity Variant Mechanism WP3407,0.5401014778225133,1.692351598173516,1.0424855977880452,['ARID5B'],0.9985648620835477,0,0,1
270,GABA metabolism (aka GHB) WP4157,0.5401014778225133,1.692351598173516,1.0424855977880452,['ABAT'],0.9985648620835477,0,0,1
271,Gene regulatory network modelling somitogenesis  WP2854,0.5401014778225133,1.692351598173516,1.0424855977880452,['RIPPLY2'],0.9985648620835477,0,0,1
272,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.5401014778225133,1.692351598173516,1.0424855977880452,['ABCB1'],0.9985648620835477,0,0,1
273,Platelet-mediated interactions with vascular and circulating cells WP4462,0.5401014778225133,1.692351598173516,1.0424855977880452,['TGFB1'],0.9985648620835477,0,0,1
274,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5401014778225133,1.692351598173516,1.0424855977880452,['RIPPLY2'],0.9985648620835477,0,0,1
275,Sulindac Metabolic Pathway WP2542,0.5401014778225133,1.692351598173516,1.0424855977880452,['MSRA'],0.9985648620835477,0,0,1
276,Tamoxifen metabolism WP691,0.5401014778225133,1.692351598173516,1.0424855977880452,['SULT1A1'],0.9985648620835477,0,0,1
277,Vitamin B6-dependent and responsive disorders WP4228,0.5401014778225133,1.692351598173516,1.0424855977880452,['PNPO'],0.9985648620835477,0,0,1
278,Sphingolipid Metabolism (integrated pathway) WP4726,0.5408379027370391,1.057664824695122,0.6500785284657662,"['UGCG', 'ASAH1', 'CERS5', 'CERS6', 'SGPP2']",0.9985648620835477,0,0,5
279,Amyotrophic lateral sclerosis (ALS) WP2447,0.5435612725357865,1.030046761516267,0.6279297334942217,"['GRIA1', 'PPP3CA', 'CCS', 'BAX', 'RAC1', 'MAP3K5', 'SOD1']",0.9985648620835477,0,0,7
280,Copper homeostasis WP3286,0.5435612725357865,1.030046761516267,0.6279297334942217,"['CCS', 'PIK3CA', 'COX17', 'MAPT', 'FOXO1', 'ATOX1', 'SOD1']",0.9985648620835477,0,0,7
281,G1 to S cell cycle control WP45,0.5463766171366873,1.0153053435114503,0.6136980314357685,"['CREB3', 'CDKN1B', 'CCND2', 'CDK6', 'GADD45A', 'RPA3', 'MCM4', 'RPA2', 'MNAT1']",0.9985648620835477,0,0,9
282,Pathways affected in adenoid cystic carcinoma WP3651,0.5491422900154067,1.006132182602771,0.6030733067891404,"['MAGI1', 'SETD2', 'MYCBP', 'PIK3CA', 'NFIB', 'MAGI2', 'JMJD1C', 'EP300', 'TLK1', 'ARID5B', 'HRAS']",0.9985648620835477,0,0,11
283,Endoderm differentiation WP2853,0.5518649536517843,0.9926300984528833,0.5900708597534902,"['SMAD2', 'TGFB1', 'STAT1', 'CTR9', 'PBX3', 'CDYL', 'TRERF1', 'EMSY', 'FOXO1', 'ACACA', 'SOX2', 'SFRP1', 'CAND1', 'RFX7', 'SESN1', 'TCEAL2', 'UBR5', 'TCF4', 'CEBPZ', 'ASCC3', 'TOX', 'BPTF']",0.9985648620835477,0,0,22
284,Corticotropin-releasing hormone signaling pathway WP2355,0.5543975337757135,0.9953193213015887,0.5871122722783845,"['NCOA2', 'HSP90AA1', 'MAP2K1', 'TGFB1', 'PRKCA', 'BRAF', 'ACACA', 'NFKB1', 'GNB2', 'GNAQ', 'GNB1', 'CRH', 'TCF4', 'GNB5', 'MAP3K5']",0.9985648620835477,0,0,15
285,PDGF Pathway WP2526,0.5630015489113581,1.002727259881018,0.5760396365635339,"['CDC42', 'TIAM1', 'MAP2K1', 'SRC', 'STAT1', 'RAC1', 'HRAS', 'NFKB1']",0.9985648620835477,0,0,8
286,Development of ureteric collection system WP5053,0.5630795235829884,1.0152878383530308,0.5831147427515849,"['GRIP1', 'FRAS1', 'ILK', 'SLIT2', 'GLI3', 'FGFR2']",0.9985648620835477,0,0,6
287,Intraflagellar transport proteins binding to dynein WP4532,0.5630795235829884,1.0152878383530308,0.5831147427515849,"['DYNC2LI1', 'DYNC2H1', 'WDR60', 'WDR19', 'DYNLL2', 'DYNC1I1']",0.9985648620835477,0,0,6
288,Nanoparticle-mediated activation of receptor signaling WP2643,0.5630795235829884,1.0152878383530308,0.5831147427515849,"['MAPK10', 'MAP2K1', 'SRC', 'PXN', 'AKT3', 'HRAS']",0.9985648620835477,0,0,6
289,PDGFR-beta pathway WP3972,0.5630795235829884,1.0152878383530308,0.5831147427515849,"['MAP2K1', 'PIK3CA', 'STAT1', 'EIF2AK2', 'PRKCA', 'HRAS']",0.9985648620835477,0,0,6
290,Cardiac Hypertrophic Response WP2795,0.5638531991729461,0.995328257305213,0.5702846185334959,"['PPP3CA', 'MAP2K1', 'CAMK2D', 'TGFB1', 'PRKCA', 'RAC1', 'PRKD1', 'CALM1', 'NFKB1', 'FGFR2']",0.9985648620835477,0,0,10
291,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5638531991729461,0.995328257305213,0.5702846185334959,"['IFI27L2', 'CAMK2D', 'PLCB4', 'STAT1', 'PRKCE', 'PRKCA', 'ISG15', 'PLCB1', 'HRAS', 'NFKB1']",0.9985648620835477,0,0,10
292,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.5654607949746155,1.0413479853479854,0.593687392200361,"['PIK3CA', 'SRC', 'NFKB1', 'TIRAP']",0.9985648620835477,0,0,4
293,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5654607949746155,1.0413479853479854,0.593687392200361,"['SMAD2', 'TGFBR3', 'RUNX2', 'FBN1']",0.9985648620835477,0,0,4
294,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5654607949746155,1.0413479853479854,0.593687392200361,"['RAB5B', 'RAB5C', 'BRAF', 'HRAS']",0.9985648620835477,0,0,4
295,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5654607949746155,1.0413479853479854,0.593687392200361,"['ATF1', 'MAP2K1', 'BRAF', 'HTR4']",0.9985648620835477,0,0,4
296,Sleep regulation WP3591,0.5654607949746155,1.0413479853479854,0.593687392200361,"['NLGN1', 'AHCY', 'CRH', 'BTBD9']",0.9985648620835477,0,0,4
297,Autosomal recessive Osteopetrosis pathways WP4788,0.5760665940192148,1.128156325339424,0.622214326106238,"['OSTM1', 'NFKB1']",0.9985648620835477,0,0,2
298,Dopamine metabolism WP2436,0.5760665940192148,1.128156325339424,0.622214326106238,"['PRKACA', 'SOD1']",0.9985648620835477,0,0,2
299,Estrogen Receptor Pathway WP2881,0.5760665940192148,1.128156325339424,0.622214326106238,"['ACOX1', 'PPARA']",0.9985648620835477,0,0,2
300,Galanin receptor pathway WP4970,0.5760665940192148,1.128156325339424,0.622214326106238,"['CDKN1B', 'PPARG']",0.9985648620835477,0,0,2
301,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.5760665940192148,1.128156325339424,0.622214326106238,"['ELOB', 'ELOC']",0.9985648620835477,0,0,2
302,Matrix Metalloproteinases WP129,0.5760665940192148,1.128156325339424,0.622214326106238,"['MMP16', 'TIMP2']",0.9985648620835477,0,0,2
303,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5760665940192148,1.128156325339424,0.622214326106238,"['DDX58', 'ADAR']",0.9985648620835477,0,0,2
304,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.5760665940192148,1.128156325339424,0.622214326106238,"['TGFB1', 'NFKB1']",0.9985648620835477,0,0,2
305,Trans-sulfuration pathway WP2333,0.5760665940192148,1.128156325339424,0.622214326106238,"['AHCY', 'GOT1']",0.9985648620835477,0,0,2
306,Cell cycle WP179,0.5812933223506849,0.9749396527110857,0.5289045585953657,"['SMAD2', 'TGFB1', 'CDKN1B', 'GADD45A', 'YWHAB', 'ANAPC10', 'STAG1', 'CCND2', 'CDC23', 'CDK6', 'STAG2', 'YWHAQ', 'CDC27', 'ABL1', 'EP300', 'MCM4', 'SKP1']",0.9985648620835477,0,0,17
307,ErbB signaling pathway WP673,0.5812933223506849,0.9749396527110857,0.5289045585953657,"['MAP2K1', 'CAMK2D', 'CDKN1B', 'SRC', 'GAB1', 'PRKCA', 'BRAF', 'FOXO1', 'MAPK10', 'NRG3', 'PIK3CA', 'RPS6KB1', 'ERBB4', 'AKT3', 'NCK2', 'ABL1', 'HRAS']",0.9985648620835477,0,0,17
308,Netrin-UNC5B signaling pathway WP4747,0.5818036043302913,0.9870169082125604,0.5345904052781032,"['MAP2K1', 'PIK3CA', 'DAPK1', 'SRC', 'PRKCA', 'FYN', 'RAC1']",0.9985648620835477,0,0,7
309,IL-18 signaling pathway WP4754,0.5836163413112958,0.9747754808791352,0.5249277691831916,"['CEBPB', 'EPB41', 'CD81', 'HSPB8', 'RGS16', 'COX17', 'KLC1', 'ACACB', 'CENPB', 'RPTOR', 'TMSB4X', 'STMN1', 'SPP1', 'LRRFIP1', 'B2M', 'ZBTB7A', 'ABCF1', 'HPS1', 'PRKCA', 'NDUFC1', 'GRIN2B', 'RUNX2', 'NFKB1', 'SLC4A7', 'ARL4D', 'RPS6KB1', 'NACA', 'SYT10', 'CYCS', 'BAX', 'HDGF', 'PPT2', 'AARS', 'ITM2C']",0.9985648620835477,0,0,34
310,22q11.2 copy number variation syndrome WP4657,0.5931961973615923,0.9667049368541906,0.5048423956596175,"['PRKN', 'RANBP1', 'CBX5', 'EMC10', 'ZDHHC8', 'RTN4', 'CDC42', 'MRPL40', 'XPO1', 'RELN', 'POLR2A', 'HIST1H4C', 'KPNB1', 'FGFR2', 'RAN', 'DGCR2']",0.9985648620835477,0,0,16
311,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5976233898527904,1.0152703731911652,0.5226556105105967,"['BAX', 'BCL2L14', 'BCL2L2']",0.9985648620835477,0,0,3
312,IL-6 signaling pathway WP364,0.5980797707893883,0.9668065623807707,0.49696867744689344,"['NCOA1', 'MAP2K1', 'RPS6KB1', 'STAT1', 'GAB1', 'RAC1', 'VIP', 'IL6ST']",0.9985648620835477,0,0,8
313,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6052648205311536,0.9663703131039815,0.4852040943530096,"['CDKN1B', 'HSP90AB1', 'ITGB5', 'COL11A1', 'SLC2A3', 'EFNA5', 'FOXO1', 'ACACA', 'IGF1R', 'HSP90B1', 'RPTOR', 'GHR', 'GNG10', 'RELN', 'PPP2R5E', 'AKT3', 'SPP1', 'HRAS', 'EIF4B', 'MAP2K1', 'HSP90AA1', 'PPP2R5B', 'VEGFD', 'CREB3', 'FGF14', 'COL4A2', 'PIK3CA', 'RAB14', 'PIK3IP1', 'RPS6KB1', 'COL4A1', 'PPP2R2B', 'CDC37', 'GNB2', 'COL5A2', 'GNB1', 'PPP2R2D', 'EIF4E2', 'FGF12', 'FGFR2', 'ATF4', 'IFNAR1']",0.9985648620835477,0,0,42
314,Glioblastoma signaling pathways WP2261,0.6057845050972455,0.9575435607974477,0.4799504765963483,"['MAP2K1', 'CDKN1B', 'SRC', 'GAB1', 'PRKCA', 'BRAF', 'FOXO1', 'IGF1R', 'CCND2', 'CDK6', 'PIK3CA', 'AKT3', 'EP300', 'HRAS', 'FGFR2']",0.9985648620835477,0,0,15
315,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6090746375402778,0.9543201896143073,0.47316575066827093,"['PIK3CA', 'MSH2', 'SRC', 'STMN1', 'PXN', 'BAX', 'RAC1', 'HRAS', 'ANGPTL1', 'FOXO1', 'NFKB1']",0.9985648620835477,0,0,11
316,1q21.1 copy number variation syndrome WP4905,0.614573939008957,0.9668571428571429,0.4706912276822346,"['TJP1', 'AFDN', 'PRKAG1', 'PRKAB1']",0.9985648620835477,0,0,4
317,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.614573939008957,0.9668571428571429,0.4706912276822346,"['MAP2K1', 'GNAQ', 'ITPR1', 'HRAS']",0.9985648620835477,0,0,4
318,Mesodermal commitment pathway WP2857,0.6157842851152868,0.9529310782286667,0.4620367934942276,"['SMAD2', 'MACF1', 'SETD2', 'PBX3', 'ARID5B', 'TRERF1', 'EMSY', 'ACACA', 'SOX2', 'LATS1', 'CCDC88A', 'PRKAR1A', 'SESN1', 'UBR5', 'RPL38', 'TCF4', 'ASCC3', 'PRKACA', 'TOX', 'TEAD1']",0.9985648620835477,0,0,20
319,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6184075177077784,0.9474294431731503,0.4553418146100917,"['GABRA2', 'NTRK2', 'GABRB1', 'ROCK1', 'PIK3CA', 'AP2B1', 'GABRG3']",0.9985648620835477,0,0,7
320,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6184075177077784,0.9474294431731503,0.4553418146100917,"['GUCY1A2', 'CAMK2D', 'AKAP9', 'CYCS', 'CALM1', 'GRIN2B', 'NFKB1']",0.9985648620835477,0,0,7
321,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6256055466274008,0.9398201179415383,0.4408087392545401,"['GRIA1', 'ACTR2', 'MAP2K1', 'CDKN1B', 'SRC', 'ERBB4', 'TMSB4X', 'MYLK', 'PFN2', 'SOD1']",0.9985648620835477,0,0,10
322,IL17 signaling pathway WP2112,0.6289859509581545,0.9399347899728997,0.43579734217614585,"['CEBPB', 'TRAF3IP2', 'PIK3CA', 'NFKB1', 'NFKBIB']",0.9985648620835477,0,0,5
323,AMP-activated protein kinase (AMPK) signaling WP1403,0.6375441012305088,0.9303571428571429,0.4187833594919776,"['RPTOR', 'PIK3CA', 'RPS6KB1', 'STRADB', 'PRKAG1', 'LEPR', 'PLCB1', 'ADIPOR1', 'PRKAB1', 'ACACB', 'ACACA']",0.9985648620835477,0,0,11
324,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6375441012305088,0.9303571428571429,0.4187833594919776,"['RYR2', 'CACNB4', 'ITGB5', 'CDH2', 'ATP2A2', 'DMD', 'CACNG2', 'EMD', 'SLC8A1', 'CACNG4', 'ACTG1']",0.9985648620835477,0,0,11
325,Biotin Metabolism (including IEMs) WP5031,0.6440549298967325,0.9668823753330795,0.425400458537108,"['ACACB', 'ACACA']",0.9985648620835477,0,0,2
326,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.6440549298967325,0.9668823753330795,0.425400458537108,"['ACOX1', 'PPARA']",0.9985648620835477,0,0,2
327,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6440549298967325,0.9668823753330795,0.425400458537108,"['GABBR1', 'GRM5']",0.9985648620835477,0,0,2
328,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.6440549298967325,0.9668823753330795,0.425400458537108,"['CDK8', 'H2AFY']",0.9985648620835477,0,0,2
329,Hypertrophy Model WP516,0.6440549298967325,0.9668823753330795,0.425400458537108,"['ZEB1', 'WDR1']",0.9985648620835477,0,0,2
330,RAS and bradykinin pathways in COVID-19 WP4969,0.6440549298967325,0.9668823753330795,0.425400458537108,"['ROCK1', 'NFKB1']",0.9985648620835477,0,0,2
331,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.6450281925904878,1.128107559614409,0.49463145489582794,['APOE'],0.9985648620835477,0,0,1
332,Cytokines and Inflammatory Response WP530,0.6450281925904878,1.128107559614409,0.49463145489582794,['TGFB1'],0.9985648620835477,0,0,1
333,FOXP3 in COVID-19 WP5063,0.6450281925904878,1.128107559614409,0.49463145489582794,['IL6ST'],0.9985648620835477,0,0,1
334,LTF danger signal response pathway WP4478,0.6450281925904878,1.128107559614409,0.49463145489582794,['NFKB1'],0.9985648620835477,0,0,1
335,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.6450281925904878,1.128107559614409,0.49463145489582794,['APOE'],0.9985648620835477,0,0,1
336,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6450281925904878,1.128107559614409,0.49463145489582794,['HIF1AN'],0.9985648620835477,0,0,1
337,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.6450281925904878,1.128107559614409,0.49463145489582794,['STRADB'],0.9985648620835477,0,0,1
338,Nanoparticle triggered regulated necrosis WP2513,0.6450281925904878,1.128107559614409,0.49463145489582794,['FTL'],0.9985648620835477,0,0,1
339,PTF1A related regulatory pathway WP4147,0.6450281925904878,1.128107559614409,0.49463145489582794,['KAT2B'],0.9985648620835477,0,0,1
340,Role of Osx and miRNAs in tooth development WP3971,0.6450281925904878,1.128107559614409,0.49463145489582794,['RUNX2'],0.9985648620835477,0,0,1
341,Spinal Cord Injury WP2431,0.6485594169211785,0.9226039531733073,0.39948904079168523,"['CDC42', 'PPP3CA', 'TGFB1', 'CDKN1B', 'COL4A1', 'GADD45A', 'APEX1', 'OMG', 'PRKCA', 'RAC1', 'SLIT2', 'RTN4']",0.9985648620835477,0,0,12
342,Peptide GPCRs WP24,0.6513133637755508,0.9228692099979229,0.3956934585099532,"['OPRD1', 'EDNRA', 'NMBR']",0.9985648620835477,0,0,3
343,Transcription factor regulation in adipogenesis WP3599,0.6513133637755508,0.9228692099979229,0.3956934585099532,"['CEBPB', 'PPARG', 'FOXO1']",0.9985648620835477,0,0,3
344,Urea cycle and associated pathways WP4595,0.6513133637755508,0.9228692099979229,0.3956934585099532,"['GOT1', 'MDH2', 'GOT2']",0.9985648620835477,0,0,3
345,EGF/EGFR signaling pathway WP437,0.6598778495853299,0.9339487179487179,0.38824298402656215,"['ATF1', 'NDUFA13', 'ROCK1', 'SRC', 'STXBP1', 'PEBP1', 'NEDD8', 'FOXO1', 'CDC42', 'ATXN2', 'RPS6KA2', 'STMN1', 'ABL1', 'NCK2', 'RICTOR', 'RAC1', 'HRAS', 'MEF2D', 'AP2M1', 'RALBP1', 'MEF2C', 'MAP2K1', 'STAT1', 'GAB1', 'PRKCA', 'BRAF', 'GAB2', 'AP2B1', 'RPS6KB1']",0.9985648620835477,0,0,29
346,Angiogenesis WP1539,0.6600663268185353,0.9022984126984127,0.3748282534532288,"['PIK3CA', 'SRC', 'TIMP2', 'FGFR2']",0.9985648620835477,0,0,4
347,Fatty Acid Biosynthesis WP357,0.6600663268185353,0.9022984126984127,0.3748282534532288,"['ECHS1', 'ACSL3', 'ACACB', 'ACACA']",0.9985648620835477,0,0,4
348,Gastric Cancer Network 2 WP2363,0.6600663268185353,0.9022984126984127,0.3748282534532288,"['AHCTF1', 'DSCC1', 'S100A6', 'CEBPZ']",0.9985648620835477,0,0,4
349,IL-7 signaling pathway WP205,0.6600663268185353,0.9022984126984127,0.3748282534532288,"['MAP2K1', 'CDKN1B', 'STAT1', 'FYN']",0.9985648620835477,0,0,4
350,B Cell Receptor Signaling Pathway WP23,0.6683774793785852,0.9106486247977644,0.3669023126463066,"['MEF2C', 'MAP2K1', 'CD81', 'GAB1', 'BRAF', 'GAB2', 'ILF2', 'FOXO1', 'NFKB1', 'CDC42', 'FYN', 'RAC1', 'HRAS', 'MEF2D']",0.9985648620835477,0,0,14
351,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6689696464518544,0.8903642490372272,0.3579412005069246,"['STAT1', 'DDX58', 'EIF2AK2', 'NFKB1', 'IFNAR1']",0.9985648620835477,0,0,5
352,CAMKK2  Pathway WP4874,0.6776471663389736,0.8825606259013078,0.3434295191063,"['RPTOR', 'MAP1LC3A', 'EP300', 'RAC1', 'CALM1', 'SQSTM1']",0.9985648620835477,0,0,6
353,Glycogen Synthesis and Degradation WP500,0.6859867804335197,0.8770517275475322,0.33055809650096707,"['PPP2R5E', 'PPP2R2B', 'PPP2R5B', 'CALM3', 'CALM1', 'GYG1', 'PHKA2']",0.9985648620835477,0,0,7
354,ATM Signaling Network in Development and Disease  WP3878,0.6939641193636366,0.8729492560091568,0.3189189347908978,"['DCLRE1C', 'KAT5', 'ATMIN', 'RBBP8', 'PPM1D', 'NFKB1', 'HMGN1', 'MAP3K5']",0.9985648620835477,0,0,8
355,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.6939641193636366,0.8729492560091568,0.3189189347908978,"['SMAD2', 'KAT2B', 'CEBPB', 'TGFB1', 'SPP1', 'PPARG', 'EMD', 'RUNX2']",0.9985648620835477,0,0,8
356,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.6996632471291309,0.8458682406702208,0.30210703174523484,"['MAP2K1', 'MAP3K11', 'MAP3K5']",0.9985648620835477,0,0,3
357,Toll-like Receptor Signaling related to MyD88 WP3858,0.6996632471291309,0.8458682406702208,0.30210703174523484,"['TOLLIP', 'NFKB1', 'TIRAP']",0.9985648620835477,0,0,3
358,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7015866446893241,0.8697709923664122,0.30825629724596976,"['RPTOR', 'NTRK2', 'PIK3CA', 'RPS6KB1', 'AKT3', 'PRKAG1', 'HRAS', 'PRKAB1', 'GRIN2B']",0.9985648620835477,0,0,9
359,Thermogenesis WP4321,0.7015932293265488,0.8950931579065943,0.31722234733234966,"['PRKAG1', 'ADCY2', 'ACSL3', 'ADCY8', 'PRKAB1', 'ARID1B', 'ACTG1', 'RPTOR', 'CREB3', 'RPS6KA6', 'ADCY9', 'RPS6KB1', 'RPS6KA2', 'PPARG', 'PRKACA', 'HRAS', 'MGLL', 'MAP3K5']",0.9985648620835477,0,0,18
360,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7017648749754835,0.8458095238095238,0.29954925102459024,"['SMAD2', 'TGFBR3', 'TGFB1', 'HRAS']",0.9985648620835477,0,0,4
361,Folate Metabolism WP176,0.7017648749754835,0.8458095238095238,0.29954925102459024,"['AHCY', 'GPX4', 'NFKB1', 'SOD1']",0.9985648620835477,0,0,4
362,Sphingolipid Metabolism (general overview) WP4725,0.7017648749754835,0.8458095238095238,0.29954925102459024,"['UGCG', 'ASAH1', 'CERS6', 'SGPP2']",0.9985648620835477,0,0,4
363,Insulin Signaling WP481,0.7022042308593681,0.910167686984296,0.3217724835523547,"['ARF1', 'STXBP4', 'STXBP1', 'FOXO1', 'IGF1R', 'RPS6KA6', 'RPS6KA2', 'RAC1', 'MAP4K5', 'MAPK6', 'GYG1', 'HRAS', 'MAP4K3', 'MAP3K5', 'MAP4K4', 'MAP2K1', 'XBP1', 'GAB1', 'PRKCA', 'INPP4A', 'EHD1', 'MAPK10', 'TBC1D4', 'PIK3CA', 'RPS6KB1', 'SGK1', 'PFKM', 'MAP3K11']",0.9985648620835477,0,0,28
364,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.703095322101435,0.8459269128283213,0.2979885854858054,"['SMURF1', 'RUNX2']",0.9985648620835477,0,0,2
365,Canonical and non-canonical TGF-B signaling WP3874,0.703095322101435,0.8459269128283213,0.2979885854858054,"['SMAD2', 'TGFB1']",0.9985648620835477,0,0,2
366,Differentiation of white and brown adipocyte WP2895,0.703095322101435,0.8459269128283213,0.2979885854858054,"['CEBPB', 'PPARG']",0.9985648620835477,0,0,2
367,Fatty acid transporters WP5061,0.703095322101435,0.8459269128283213,0.2979885854858054,"['FABP5', 'ACSL3']",0.9985648620835477,0,0,2
368,Kynurenine Pathway and links to Cellular Senescence WP5044,0.703095322101435,0.8459269128283213,0.2979885854858054,"['KMO', 'FOXO1']",0.9985648620835477,0,0,2
369,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.703095322101435,0.8459269128283213,0.2979885854858054,"['IDI1', 'PMVK']",0.9985648620835477,0,0,2
370,Nuclear receptors WP170,0.7060040952999243,0.8457507621951219,0.29443479950079965,"['THRA', 'RORA', 'PPARG', 'NR2F2', 'PPARA']",0.9985648620835477,0,0,5
371,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7066366782816192,0.8792889908256881,0.3053231109483635,"['MAP2K1', 'CAMK2D', 'TGFB1', 'ROCK1', 'NFKB1', 'IGF1R', 'MYLK', 'PPP3CA', 'PIK3CA', 'RAC1', 'IL6ST', 'CALM1', 'FGFR2']",0.9985648620835477,0,0,13
372,Nucleotide Excision Repair WP4753,0.7224421755439557,0.8455742083174361,0.27491130756030135,"['POLE4', 'GTF2H2C', 'RPA3', 'POLD2', 'RPA2', 'GTF2H3', 'MNAT1', 'GTF2H5']",0.9985648620835477,0,0,8
373,DNA Repair Pathways Full Network WP4946,0.7225347675505703,0.887447277607362,0.2884112591046463,"['XRCC6', 'DCLRE1C', 'GTF2H2C', 'MPG', 'XRCC5', 'MGMT', 'REV1', 'RPA2', 'FANCC', 'GTF2H3', 'GTF2H5', 'POLE4', 'BRIP1', 'NEIL2', 'MSH2', 'RPA3', 'APEX1', 'POLD2', 'REV3L', 'USP1', 'MNAT1']",0.9985648620835477,0,0,21
374,Acetylcholine Synthesis WP528,0.7260226330417812,0.8459855403348554,0.27086265023766004,['PDHA1'],0.9985648620835477,0,0,1
375,Farnesoid X receptor pathway WP2879,0.7260226330417812,0.8459855403348554,0.27086265023766004,['FKBP5'],0.9985648620835477,0,0,1
376,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.7260226330417812,0.8459855403348554,0.27086265023766004,['CEBPB'],0.9985648620835477,0,0,1
377,Irinotecan pathway WP229,0.7260226330417812,0.8459855403348554,0.27086265023766004,['CES2'],0.9985648620835477,0,0,1
378,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.7260226330417812,0.8459855403348554,0.27086265023766004,['FADS1'],0.9985648620835477,0,0,1
379,miRNA Biogenesis WP2338,0.7260226330417812,0.8459855403348554,0.27086265023766004,['RAN'],0.9985648620835477,0,0,1
380,NAD Biosynthesis II (from tryptophan) WP2485,0.7260226330417812,0.8459855403348554,0.27086265023766004,['KMO'],0.9985648620835477,0,0,1
381,SARS-CoV-2 and COVID-19 Pathway WP4846,0.7260226330417812,0.8459855403348554,0.27086265023766004,['CTSL'],0.9985648620835477,0,0,1
382,Focal Adhesion WP306,0.7334580053821768,0.8927915968459156,0.2767519454865481,"['ITGB5', 'ROCK1', 'SRC', 'PXN', 'ILK', 'MYLK', 'MYL12B', 'ACTG1', 'IGF1R', 'CDC42', 'RELN', 'CCND2', 'AKT3', 'SPP1', 'FYN', 'RAC1', 'HRAS', 'MAP2K1', 'PPP1R12A', 'PRKCA', 'PARVA', 'BRAF', 'VEGFD', 'MAPK10', 'COL4A2', 'PIK3CA', 'COL4A1', 'COL5A2']",0.9985648620835477,0,0,28
383,Apoptosis WP254,0.733822898894789,0.8454562810232913,0.2616582028875715,"['HRK', 'MAPK10', 'CRADD', 'CASP2', 'CYCS', 'BAX', 'NFKB1', 'BCL2L2', 'IGF1R', 'NFKBIB']",0.9985648620835477,0,0,10
384,Cannabinoid receptor signaling WP3869,0.7396300022302135,0.7959663865546218,0.24006761299858045,"['MAPK10', 'DAGLA', 'PRKAR1A', 'PRKACA']",0.9985648620835477,0,0,4
385,Lung fibrosis WP3624,0.7396300022302135,0.7959663865546218,0.24006761299858045,"['CEBPB', 'TGFB1', 'FAM13A', 'SPP1']",0.9985648620835477,0,0,4
386,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.7398865347245116,0.8763917291524653,0.26402040164233287,"['RYR2', 'NTRK2', 'MEF2C', 'ADCYAP1R1', 'CEBPB', 'CHRNA4', 'YWHAB', 'ATP1A3', 'RORA', 'YBX1', 'NFKB1', 'HSP90B1', 'HSPD1', 'SOX2', 'YWHAQ', 'PRKAR1A', 'SST', 'PLP1', 'EP300', 'PRKACA', 'SLC25A4']",0.9985648620835477,0,0,21
387,Alpha 6 Beta 4 signaling pathway WP244,0.7400337181370858,0.8053861788617886,0.24246918348749982,"['SRC', 'GAB1', 'PRKCA', 'RAC1', 'HRAS']",0.9985648620835477,0,0,5
388,Base Excision Repair WP4752,0.7400337181370858,0.8053861788617886,0.24246918348749982,"['POLE4', 'NEIL2', 'MPG', 'APEX1', 'POLD2']",0.9985648620835477,0,0,5
389,Integrin-mediated Cell Adhesion WP185,0.741028644751796,0.8595826903375565,0.25763068350968066,"['MAP2K1', 'ITGB5', 'ROCK1', 'SRC', 'PXN', 'ILK', 'BRAF', 'CDC42', 'MAPK10', 'AKT3', 'FYN', 'RAC1', 'MAPK6', 'HRAS', 'TNS1']",0.9985648620835477,0,0,15
390,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7422161756688198,0.8117727792603888,0.24200142808547684,"['MAP2K1', 'PIK3CA', 'SRC', 'PXN', 'GAB1', 'HRAS']",0.9985648620835477,0,0,6
391,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7427245946189673,0.7807135743160115,0.23220761476032264,"['H3F3B', 'H2AFY', 'H2AFZ']",0.9985648620835477,0,0,3
392,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7427245946189673,0.7807135743160115,0.23220761476032264,"['TTC9', 'CEBPB', 'ERBB4']",0.9985648620835477,0,0,3
393,Ovarian infertility WP34,0.7427245946189673,0.7807135743160115,0.23220761476032264,"['CEBPB', 'CDKN1B', 'CCND2']",0.9985648620835477,0,0,3
394,Zinc homeostasis WP3529,0.7427245946189673,0.7807135743160115,0.23220761476032264,"['SLC39A6', 'SLC39A11', 'SLC39A7']",0.9985648620835477,0,0,3
395,BMP Signaling Pathway in Eyelid Development WP3927,0.7537311429728506,0.751850441991287,0.2125628177763436,"['SFRP1', 'FGFR2']",0.9985648620835477,0,0,2
396,FOXA2 pathway WP5066,0.7537311429728506,0.751850441991287,0.2125628177763436,"['ACACA', 'FOXO1']",0.9985648620835477,0,0,2
397,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7537311429728506,0.751850441991287,0.2125628177763436,"['NFKB1', 'BCL2L2']",0.9985648620835477,0,0,2
398,Serotonin and anxiety WP3947,0.7537311429728506,0.751850441991287,0.2125628177763436,"['PPP3CA', 'CRH']",0.9985648620835477,0,0,2
399,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7537311429728506,0.751850441991287,0.2125628177763436,"['ITPR1', 'NFKB1']",0.9985648620835477,0,0,2
400,Tryptophan catabolism leading to NAD+ production WP4210,0.7537311429728506,0.751850441991287,0.2125628177763436,"['NMRK1', 'KMO']",0.9985648620835477,0,0,2
401,TYROBP causal network in microglia WP3945,0.7537311429728506,0.751850441991287,0.2125628177763436,"['DPYD', 'SPP1']",0.9985648620835477,0,0,2
402,Regulation of toll-like receptor signaling pathway WP1449,0.7552915214950198,0.8452198852772467,0.2372122143260677,"['MAP2K1', 'CUEDC2', 'STAT1', 'NFKB1', 'TIRAP', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'SPP1', 'TAB2', 'RAC1', 'SQSTM1', 'IFNAR1']",0.9985648620835477,0,0,14
403,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7807096418725898,0.7248667174409749,0.17944218797865585,"['CBX5', 'RBBP4', 'H3F3B']",0.9985648620835477,0,0,3
404,Monoamine GPCRs WP58,0.7807096418725898,0.7248667174409749,0.17944218797865585,"['CHRM5', 'HTR4', 'HTR5A']",0.9985648620835477,0,0,3
405,Purine metabolism and related disorders WP4224,0.7807096418725898,0.7248667174409749,0.17944218797865585,"['PRPS1', 'GRM5', 'PFAS']",0.9985648620835477,0,0,3
406,TLR4 Signaling and Tolerance WP3851,0.7807096418725898,0.7248667174409749,0.17944218797865585,"['TAB2', 'NFKB1', 'TIRAP']",0.9985648620835477,0,0,3
407,ATR Signaling WP3875,0.7885417957900583,0.6767123287671233,0.16076645812844995,['TOPBP1'],0.9985648620835477,0,0,1
408,Biomarkers for urea cycle disorders WP4583,0.7885417957900583,0.6767123287671233,0.16076645812844995,['GOT1'],0.9985648620835477,0,0,1
409,"Degradation pathway of sphingolipids, including diseases WP4153",0.7885417957900583,0.6767123287671233,0.16076645812844995,['NEU1'],0.9985648620835477,0,0,1
410,Methylation Pathways WP704,0.7885417957900583,0.6767123287671233,0.16076645812844995,['NNMT'],0.9985648620835477,0,0,1
411,Pilocytic astrocytoma WP2253,0.7885417957900583,0.6767123287671233,0.16076645812844995,['BRAF'],0.9985648620835477,0,0,1
412,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.7885417957900583,0.6767123287671233,0.16076645812844995,['NFKB1'],0.9985648620835477,0,0,1
413,Type III interferon signaling WP2113,0.7885417957900583,0.6767123287671233,0.16076645812844995,['STAT1'],0.9985648620835477,0,0,1
414,Valproic acid pathway WP3871,0.7885417957900583,0.6767123287671233,0.16076645812844995,['ABAT'],0.9985648620835477,0,0,1
415,Hippo-Merlin Signaling Dysregulation WP4541,0.7959392610915971,0.8177123182861515,0.1866284459018131,"['NTRK2', 'PPP1R14A', 'PPP1R12A', 'ITGB5', 'IGF1R', 'LATS1', 'PLCB4', 'CDH2', 'PRKAR1A', 'CDH13', 'PRKACA', 'HRAS', 'TEAD1', 'FGFR2', 'CDH18']",0.9985648620835477,0,0,15
416,Glucocorticoid Receptor Pathway WP2880,0.7963334764974024,0.7635392829900839,0.17388632935615944,"['TGFBR3', 'EPB41L4B', 'AKAP13', 'HSP90AA1', 'NAV3', 'ABHD2', 'CDC42EP3']",0.9985648620835477,0,0,7
417,ERK Pathway in Huntington's Disease WP3853,0.7967234247672645,0.6765892653216596,0.15375334138818456,"['NTRK2', 'HRAS']",0.9985648620835477,0,0,2
418,GDNF/RET signaling axis WP4830,0.7967234247672645,0.6765892653216596,0.15375334138818456,"['SLIT2', 'GLI3']",0.9985648620835477,0,0,2
419,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.7967234247672645,0.6765892653216596,0.15375334138818456,"['ECI1', 'ACSL3']",0.9985648620835477,0,0,2
420,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7967234247672645,0.6765892653216596,0.15375334138818456,"['TGFB1', 'CDC37']",0.9985648620835477,0,0,2
421,One-carbon metabolism and related pathways WP3940,0.7969219726471481,0.7514720210107172,0.1705830262998741,"['GPX4', 'GAD1', 'GAD2', 'BCAT1', 'CDO1', 'SOD1']",0.9985648620835477,0,0,6
422,ATM Signaling Pathway WP2516,0.7991977305735837,0.7351869034994698,0.1647898589251085,"['CRADD', 'GADD45A', 'ABL1', 'CASP2', 'TLK1']",0.9985648620835477,0,0,5
423,DNA Replication WP466,0.7991977305735837,0.7351869034994698,0.1647898589251085,"['RPA3', 'POLD2', 'RPA2', 'MCM4', 'UBA52']",0.9985648620835477,0,0,5
424,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7991977305735837,0.7351869034994698,0.1647898589251085,"['PPP3CA', 'SUPT4H1', 'EP300', 'SUPT5H', 'NFKB1']",0.9985648620835477,0,0,5
425,Tumor suppressor activity of SMARCB1 WP4204,0.7991977305735837,0.7351869034994698,0.1647898589251085,"['CDK6', 'RBBP4', 'H3F3B', 'ARID1B', 'GLI3']",0.9985648620835477,0,0,5
426,Fluoropyrimidine Activity WP1601,0.8139367284870073,0.6764661081492764,0.13926586702691077,"['DPYD', 'UMPS', 'CES2']",0.9985648620835477,0,0,3
427,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8139367284870073,0.6764661081492764,0.13926586702691077,"['B3GALNT1', 'UGCG', 'SGPP2']",0.9985648620835477,0,0,3
428,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8139367284870073,0.6764661081492764,0.13926586702691077,"['GOT1', 'MDH2', 'GOT2']",0.9985648620835477,0,0,3
429,Oxidation by Cytochrome P450 WP43,0.8139367284870073,0.6764661081492764,0.13926586702691077,"['CYB5B', 'CYP4Z1', 'CYB5R3']",0.9985648620835477,0,0,3
430,Trans-sulfuration and one-carbon metabolism WP2525,0.8139367284870073,0.6764661081492764,0.13926586702691077,"['AHCYL2', 'AHCY', 'AMT']",0.9985648620835477,0,0,3
431,Tryptophan metabolism WP465,0.8139367284870073,0.6764661081492764,0.13926586702691077,"['ECHS1', 'WARS', 'DHCR24']",0.9985648620835477,0,0,3
432,Notch Signaling Pathway Netpath WP61,0.818011042817072,0.7512823773792869,0.15091718527387932,"['NUMBL', 'SRC', 'FHL1', 'NUMB', 'EP300', 'MAPT', 'NFKB1', 'SKP1']",0.9985648620835477,0,0,8
433,Histone Modifications WP2369,0.8187267410278944,0.7395952517162472,0.14792267461222128,"['KMT2E', 'SETD2', 'SET', 'H3F3B', 'EHMT1', 'SMYD3', 'HIST1H4C']",0.9985648620835477,0,0,7
434,IL-4 signaling pathway WP395,0.8187267410278944,0.7395952517162472,0.14792267461222128,"['CEBPB', 'PIK3CA', 'RPS6KB1', 'STAT1', 'EP300', 'GAB2', 'NFKB1']",0.9985648620835477,0,0,7
435,MET in type 1 papillary renal cell carcinoma WP4205,0.8189419519714364,0.7682495053629074,0.15345174982315435,"['CDC42', 'MAP2K1', 'PIK3CA', 'SRC', 'AKT3', 'RPL11', 'GAB1', 'BRAF', 'RAC1', 'HRAS']",0.9985648620835477,0,0,10
436,Small cell lung cancer WP4658,0.8217259939874698,0.7799594368184357,0.15314369400149766,"['CDKN1B', 'CDK6', 'PIK3CA', 'COL4A2', 'COL4A1', 'GADD45A', 'AKT3', 'CYCS', 'BAX', 'NFKB1', 'SKP1', 'NFKBIB']",0.9985648620835477,0,0,12
437,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8235282264720806,0.7845470183486238,0.15232565141081214,"['MAP2K1', 'SRC', 'GAB1', 'PRKCA', 'BRAF', 'IGF1R', 'PIK3CA', 'RPS6KB1', 'AKT3', 'BAX', 'EIF4E2', 'HRAS', 'FGFR2']",0.9985648620835477,0,0,13
438,Phosphoinositides metabolism WP4971,0.824520724675855,0.7044747205284553,0.13593051162733819,"['PIP4P1', 'PLCB4', 'PIK3CA', 'PLCB1', 'SBF2']",0.9985648620835477,0,0,5
439,Signal transduction through IL1R WP4496,0.8312441090356655,0.6763428571428571,0.1250096500581356,"['TGFB1', 'TOLLIP', 'IL1RAP', 'NFKB1']",0.9985648620835477,0,0,4
440,Circadian rhythm related genes WP3594,0.8315583561152552,0.8283837951855262,0.15279853976978422,"['NLGN1', 'AHCY', 'BHLHE41', 'RORA', 'RORB', 'DBP', 'EP300', 'BTRC', 'RPS27A', 'SKP1', 'NCOA2', 'KCND2', 'USP2', 'BTBD9', 'MAPK10', 'PSPC1', 'ID2', 'GNAQ', 'CRY2', 'CRH', 'CRY1', 'PPARG', 'ATF5', 'PPARA', 'UBA52', 'ATF4']",0.9985648620835477,0,0,26
441,IL-9 signaling pathway WP22,0.8329233632209847,0.6150119389556009,0.11243257242339681,"['MAP2K1', 'STAT1']",0.9985648620835477,0,0,2
442,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8329233632209847,0.6150119389556009,0.11243257242339681,"['ROCK1', 'FGFR2']",0.9985648620835477,0,0,2
443,MAPK pathway in congenital thyroid cancer WP4928,0.8329233632209847,0.6150119389556009,0.11243257242339681,"['MAP2K1', 'BRAF']",0.9985648620835477,0,0,2
444,Omega-9 FA synthesis WP4724,0.8329233632209847,0.6150119389556009,0.11243257242339681,"['ACSL3', 'FADS1']",0.9985648620835477,0,0,2
445,Endometrial cancer WP4155,0.8366803656581674,0.7419847328244275,0.13230564413413137,"['MAP2K1', 'PIK3CA', 'GADD45A', 'AKT3', 'ILK', 'BAX', 'BRAF', 'HRAS', 'FGFR2']",0.9985648620835477,0,0,9
446,Canonical NF-KB pathway WP4562,0.8367987492889932,0.5638635210553019,0.1004645110108761,['NFKB1'],0.9985648620835477,0,0,1
447,"Cerebral organic acidurias, including diseases WP4519",0.8367987492889932,0.5638635210553019,0.1004645110108761,['MDH2'],0.9985648620835477,0,0,1
448,Glial Cell Differentiation WP2276,0.8367987492889932,0.5638635210553019,0.1004645110108761,['PLP1'],0.9985648620835477,0,0,1
449,Heme Biosynthesis WP561,0.8367987492889932,0.5638635210553019,0.1004645110108761,['UROS'],0.9985648620835477,0,0,1
450,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.8367987492889932,0.5638635210553019,0.1004645110108761,['STAT1'],0.9985648620835477,0,0,1
451,Mevalonate pathway WP3963,0.8367987492889932,0.5638635210553019,0.1004645110108761,['PMVK'],0.9985648620835477,0,0,1
452,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.8367987492889932,0.5638635210553019,0.1004645110108761,['STAG1'],0.9985648620835477,0,0,1
453,Supression of HMGB1 mediated inflammation by THBD WP4479,0.8367987492889932,0.5638635210553019,0.1004645110108761,['NFKB1'],0.9985648620835477,0,0,1
454,EPO Receptor Signaling WP581,0.8427873741165085,0.6341155750190404,0.1084594944965269,"['MAP2K1', 'SRC', 'STAT1']",0.9985648620835477,0,0,3
455,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8471911073246489,0.676219512195122,0.11213679284107615,"['MAPK10', 'MAP2K1', 'RPS6KA2', 'DDIT3', 'MAP3K11']",0.9985648620835477,0,0,5
456,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8576937903727713,0.6959326064521919,0.10683131362877116,"['MAPK10', 'MAP2K1', 'TOLLIP', 'TAB2', 'IL1RAP', 'NFKB1', 'NFKBIB']",0.9985648620835477,0,0,7
457,Microglia Pathogen Phagocytosis Pathway WP3937,0.8631916281858867,0.5636975003172187,0.08293036658826428,"['PIK3CA', 'RAC1']",0.9985648620835477,0,0,2
458,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8631916281858867,0.5636975003172187,0.08293036658826428,"['EI24', 'BAX']",0.9985648620835477,0,0,2
459,Triacylglyceride synthesis WP325,0.8631916281858867,0.5636975003172187,0.08293036658826428,"['AGPAT1', 'PLPP1']",0.9985648620835477,0,0,2
460,Regulation of Actin Cytoskeleton WP51,0.8643975369584199,0.7879473415132925,0.11482165944963584,"['CYFIP2', 'NCKAP1', 'MAP2K1', 'PPP1R12A', 'ROCK1', 'CHRM5', 'PXN', 'BRK1', 'BRAF', 'SSH2', 'MYLK', 'ACTG1', 'CDC42', 'FGF14', 'PIK3CA', 'CFL2', 'TMSB4X', 'RAC1', 'MAPK6', 'FGF12', 'FGFR2']",0.9985648620835477,0,0,21
461,MAPK Signaling Pathway WP382,0.8648031962860924,0.825978185268856,0.11997607091643471,"['RASGRF2', 'DUSP16', 'CDC42', 'PPP3CA', 'STMN1', 'AKT3', 'RAC1', 'PRKACA', 'CACNG2', 'HRAS', 'MAP4K3', 'CACNG4', 'MAP4K4', 'MAP3K5', 'NTRK2', 'MEF2C', 'MAP2K1', 'TGFB1', 'GADD45A', 'PLA2G4C', 'PRKCA', 'BRAF', 'NFKB1', 'MAPK10', 'CACNB4', 'FGF14', 'DDIT3', 'TAOK1', 'RAPGEF2', 'TAB2', 'MAPT', 'FGF12', 'MAP3K11', 'FGFR2', 'ATF4']",0.9985648620835477,0,0,35
462,Male infertility WP4673,0.8669391306007618,0.7371660819119742,0.10525737329554818,"['PACRG', 'ABLIM1', 'CCNT2', 'ABCB1', 'UBE2B', 'XRCC5', 'PON2', 'EP300', 'TEX15', 'CHD2', 'CDC42BPA', 'SOX5']",0.9985648620835477,0,0,12
463,Metapathway biotransformation Phase I and II WP702,0.8670427994722658,0.7444021147566475,0.10620157065088578,"['GSTM3', 'NAA30', 'NNMT', 'GPX4', 'GSTO1', 'NAA20', 'MGST3', 'KCNAB1', 'NAT14', 'NDST2', 'SULT1A1', 'CYP4Z1', 'SULT4A1']",0.9985648620835477,0,0,13
464,DNA IR-damage and cellular response via ATR WP4016,0.8672033603836724,0.7287856318998187,0.10383866920547558,"['UPF1', 'BRIP1', 'MSH2', 'POLN', 'XRCC5', 'RBBP8', 'USP1', 'RPA2', 'TOPBP1', 'PPM1D', 'MCPH1']",0.9985648620835477,0,0,11
465,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8672033603836724,0.7287856318998187,0.10383866920547558,"['IDI1', 'CDK8', 'SEC24B', 'PIK3CA', 'PRKAG1', 'PPARG', 'PRKACA', 'PRKAB1', 'SEC23B', 'KPNB1', 'ACACA']",0.9985648620835477,0,0,11
466,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.867673642518212,0.596747457551185,0.08470210909445045,"['MAP2K1', 'THRA', 'STAT1']",0.9985648620835477,0,0,3
467,Non-small cell lung cancer WP4255,0.8679327383921646,0.7189685847286198,0.10183547076234552,"['MAP2K1', 'CDK6', 'PIK3CA', 'GADD45A', 'AKT3', 'CYCS', 'BAX', 'PRKCA', 'BRAF', 'HRAS']",0.9985648620835477,0,0,10
468,Cancer immunotherapy by CTLA4 blockade WP4582,0.874046104789917,0.4832572298325723,0.06505712884984151,['PIK3CA'],0.9985648620835477,0,0,1
469,Glutathione metabolism WP100,0.874046104789917,0.4832572298325723,0.06505712884984151,['GPX4'],0.9985648620835477,0,0,1
470,Homologous recombination WP186,0.874046104789917,0.4832572298325723,0.06505712884984151,['POLD2'],0.9985648620835477,0,0,1
471,ID signaling pathway WP53,0.874046104789917,0.4832572298325723,0.06505712884984151,['ID2'],0.9985648620835477,0,0,1
472,Mitochondrial CII Assembly WP4920,0.874046104789917,0.4832572298325723,0.06505712884984151,['SDHAF1'],0.9985648620835477,0,0,1
473,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8744566213973132,0.6759725400457666,0.09068346677591446,"['IDI1', 'EBP', 'PMVK', 'DHCR24', 'ACSL3', 'FADS1', 'TM7SF2']",0.9985648620835477,0,0,7
474,PPAR signaling pathway WP3942,0.8789240318255187,0.6542127335112466,0.08443060891536984,"['FABP5', 'ACOX1', 'ILK', 'PPARG', 'ACSL3', 'PPARA']",0.9985648620835477,0,0,6
475,Retinoblastoma gene in cancer WP2446,0.8816761241592797,0.7039105256459208,0.08864380204294235,"['ANLN', 'CDKN1B', 'CDK6', 'RBBP4', 'H2AFZ', 'RPA3', 'STMN1', 'ABL1', 'MCM4', 'RPA2']",0.9985648620835477,0,0,10
476,IL-1 signaling pathway WP195,0.886001601423262,0.6758489126287677,0.08180240104081343,"['MAP2K1', 'TOLLIP', 'UBE2N', 'TAB2', 'IL1RAP', 'SQSTM1', 'NFKB1', 'NFKBIB']",0.9985648620835477,0,0,8
477,Cholesterol Biosynthesis Pathway WP197,0.8883497726552154,0.5202775907001259,0.06159552110427619,"['IDI1', 'PMVK']",0.9985648620835477,0,0,2
478,Ebstein-Barr virus LMP1 signaling WP262,0.8883497726552154,0.5202775907001259,0.06159552110427619,"['HSP90AA1', 'NFKB1']",0.9985648620835477,0,0,2
479,miRNAs involvement in the immune response in sepsis WP4329,0.8883497726552154,0.5202775907001259,0.06159552110427619,"['TAB2', 'NFKB1']",0.9985648620835477,0,0,2
480,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8895481265288713,0.6571213662174761,0.07691058090682229,"['LATS1', 'UPF1', 'DCLRE1C', 'KAT5', 'ABL1', 'BAX', 'MCPH1']",0.9985648620835477,0,0,7
481,Prader-Willi and Angelman Syndrome WP3998,0.9010414051418905,0.6035632621951219,0.06289374708160551,"['CCND2', 'CDK6', 'FEZ1', 'NDN', 'GABRG3']",0.9985648620835477,0,0,5
482,Ectoderm Differentiation WP2858,0.9012527114734432,0.7458299919807538,0.07754363237341415,"['NLGN1', 'TSC22D1', 'SMURF1', 'CTNND2', 'NR2F2', 'LDB2', 'PTPN13', 'CELSR2', 'GLI3', 'SOX2', 'PLCXD3', 'ARHGEF9', 'MAFB', 'DMD', 'FYN', 'PDE7A', 'FGFR2', 'ANKS1B', 'ASTN1']",0.9985648620835477,0,0,19
483,15q11.2 copy number variation syndrome WP4940,0.9027949080121694,0.4228025114155251,0.043235731659058675,['TUBGCP4'],0.9985648620835477,0,0,1
484,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.9027949080121694,0.4228025114155251,0.043235731659058675,['MAP2K1'],0.9985648620835477,0,0,1
485,GPR40 Pathway WP3958,0.9027949080121694,0.4228025114155251,0.043235731659058675,['PLCB1'],0.9985648620835477,0,0,1
486,Iron metabolism in placenta WP2007,0.9027949080121694,0.4228025114155251,0.043235731659058675,['TFR2'],0.9985648620835477,0,0,1
487,Purine metabolism WP4792,0.9027949080121694,0.4228025114155251,0.043235731659058675,['PRPS1'],0.9985648620835477,0,0,1
488,Wnt signaling pathway and pluripotency WP399,0.903858775399973,0.6880641145347027,0.06955100189041867,"['SOX2', 'MAPK10', 'CCND2', 'PPP2R5E', 'PPP2R2B', 'PRKCE', 'EP300', 'PRKCA', 'PRKD1', 'FBXW2', 'PAFAH1B1']",0.9985648620835477,0,0,11
489,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9081702300189674,0.6144248431705542,0.05918351448995879,"['MAPK10', 'DDX58', 'TRIM25', 'ISG15', 'NFKB1', 'NFKBIB']",0.9985648620835477,0,0,6
490,Monoamine Transport WP727,0.9091533021257634,0.4830605253140464,0.04600743308829304,"['AMPH', 'SLC6A1']",0.9985648620835477,0,0,2
491,Autophagy WP4923,0.9101173524319112,0.5633650793650794,0.05305869727187555,"['RPTOR', 'MAP1LC3B', 'PRKAG1', 'PRKAB1']",0.9985648620835477,0,0,4
492,"GPCRs, Class A Rhodopsin-like WP455",0.9111534437481874,0.6435202848785451,0.05987567660743792,"['OPRD1', 'EDNRA', 'P2RY14', 'CHRM5', 'RRH', 'NMBR', 'HTR4', 'HTR5A']",0.9985648620835477,0,0,8
493,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9174819508758694,0.7287138627655869,0.0627585658728023,"['MAP2K1', 'THRA', 'PRKAG1', 'PRKAB1', 'FOXO1', 'RPTOR', 'MAPK10', 'RPS6KA6', 'PIK3CA', 'RPS6KB1', 'RPS6KA2', 'RICTOR', 'MAP4K5', 'MAPK6', 'HRAS', 'MAP3K11', 'MAP4K3', 'MAP3K5', 'MAP4K4']",0.9985648620835477,0,0,19
494,DNA damage response (only ATM dependent) WP710,0.920257373561444,0.6858574636850153,0.056996054377763165,"['TGFB1', 'CDKN1B', 'NFKB1', 'CDC42', 'MAPK10', 'CCND2', 'PIK3CA', 'PPP2R5E', 'AKT3', 'ABL1', 'BAX', 'RAC1', 'HRAS']",0.9985648620835477,0,0,13
495,Neovascularisation processes WP4331,0.9226702262420304,0.507063975628332,0.04081022922605564,"['SMAD2', 'TGFB1', 'NFKB1']",0.9985648620835477,0,0,3
496,Osteoblast differentiation WP4787,0.9232815878959117,0.6633403361344538,0.052948496950082156,"['MAPK10', 'PIK3CA', 'STAT1', 'PRKCE', 'PRKCA', 'PPARG', 'PRKD1', 'MAPK6', 'RUNX2', 'FGFR2', 'GLI3']",0.9985648620835477,0,0,11
497,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9238127669261887,0.5407695238095238,0.04285374655475276,"['TGFB1', 'COL4A2', 'RAC1', 'NFKB1']",0.9985648620835477,0,0,4
498,IL-5 signaling pathway WP127,0.9238127669261887,0.5407695238095238,0.04285374655475276,"['MAP2K1', 'RPS6KB1', 'STAT1', 'MAPT']",0.9985648620835477,0,0,4
499,Ganglio Sphingolipid Metabolism WP1423,0.924983659515953,0.37578217486893284,0.029303196006240196,['ST8SIA1'],0.9985648620835477,0,0,1
500,Glycosaminoglycan degradation WP4815,0.924983659515953,0.37578217486893284,0.029303196006240196,['HPSE2'],0.9985648620835477,0,0,1
501,Mammalian disorder of sexual development WP4842,0.924983659515953,0.37578217486893284,0.029303196006240196,['FGFR2'],0.9985648620835477,0,0,1
502,PPAR-alpha pathway WP2878,0.924983659515953,0.37578217486893284,0.029303196006240196,['PPARA'],0.9985648620835477,0,0,1
503,7-oxo-C and 7beta-HC pathways WP5064,0.9262790573253591,0.45080573531277757,0.034522582363812136,"['EBP', 'DBP']",0.9985648620835477,0,0,2
504,Modulators of TCR signaling and T cell activation WP5072,0.9310911566325806,0.5791841402973694,0.04135264363206534,"['CDKN1B', 'NDUFB10', 'ELOB', 'RNF7', 'MEF2D', 'NFKB1']",0.9985648620835477,0,0,6
505,MAPK Cascade WP422,0.9356006691392033,0.5199120879120879,0.03460874311614112,"['MAPK10', 'MAP2K1', 'BRAF', 'HRAS']",0.9985648620835477,0,0,4
506,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9375645794545229,0.5449695121951219,0.03513398758562945,"['MAP2K1', 'PIK3CA', 'FYN', 'CALM1', 'NFKB1']",0.9985648620835477,0,0,5
507,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9403217836495618,0.4225827940616673,0.02600284591832722,"['MDH2', 'IDH3B']",0.9985648620835477,0,0,2
508,Vitamin D in inflammatory diseases WP4482,0.9403217836495618,0.4225827940616673,0.02600284591832722,"['PPP3CA', 'NFKB1']",0.9985648620835477,0,0,2
509,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.9421088226873681,0.33816590563165905,0.02016635066012144,['MADD'],0.9985648620835477,0,0,1
510,Leptin Insulin Overlap WP3935,0.9421088226873681,0.33816590563165905,0.02016635066012144,['LEPR'],0.9985648620835477,0,0,1
511,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.9421088226873681,0.33816590563165905,0.02016635066012144,['NFKB1'],0.9985648620835477,0,0,1
512,NOTCH1 regulation of endothelial cell calcification WP3413,0.9421088226873681,0.33816590563165905,0.02016635066012144,['SOX6'],0.9985648620835477,0,0,1
513,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.9421088226873681,0.33816590563165905,0.02016635066012144,['TCF4'],0.9985648620835477,0,0,1
514,Riboflavin and CoQ disorders WP5037,0.9421088226873681,0.33816590563165905,0.02016635066012144,['PDSS2'],0.9985648620835477,0,0,1
515,Integrated breast cancer pathway WP1984,0.9429911851899702,0.7027756483965759,0.04125176677635445,"['ATF1', 'SMAD2', 'RALGAPA1', 'GADD45A', 'STAT1', 'ZMYND8', 'ODC1', 'BRAF', 'PHB', 'FOXO1', 'NFKB1', 'CDC42', 'FER', 'MSH2', 'ABL1', 'EP300', 'BAX', 'RAC1', 'FAU', 'RPP38']",0.9985648620835477,0,0,20
516,Glycerophospholipid Biosynthetic Pathway WP2533,0.94672623288121,0.46086339403171084,0.025230112331227128,"['PIK3CA', 'CDIPT', 'CDS2']",0.9985648620835477,0,0,3
517,Ciliopathies WP4803,0.9517589455399256,0.714269442057851,0.035315970244287925,"['IFT172', 'CCDC28B', 'GLI3', 'DYNC2LI1', 'TBC1D32', 'TCTN3', 'CSPP1', 'NEK1', 'BBS9', 'RAB28', 'CEP290', 'CEP78', 'DYNC2H1', 'WDR19', 'SCLT1', 'POMGNT1', 'TTLL5', 'WDR60', 'NME7', 'NME9', 'SPAG1', 'CCDC65', 'CEP41', 'KIZ', 'TRIM32']",0.9985648620835477,0,0,25
518,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.9553255918306208,0.3073889580738896,0.014048616840151707,['ACOX1'],0.9985648620835477,0,0,1
519,Statin inhibition of cholesterol production WP430,0.9553255918306208,0.3073889580738896,0.014048616840151707,['APOE'],0.9985648620835477,0,0,1
520,Type II diabetes mellitus WP1584,0.9553255918306208,0.3073889580738896,0.014048616840151707,['PHKA2'],0.9985648620835477,0,0,1
521,Fatty acid beta-oxidation WP143,0.9559486987548681,0.44077618464187557,0.019857421012205324,"['ECHS1', 'ECI1', 'ACSL3']",0.9985648620835477,0,0,3
522,ESC Pluripotency Pathways WP3931,0.9578001204933527,0.6086237773798043,0.026241523373629765,"['ACTR2', 'MAP2K1', 'FGF14', 'AKT3', 'GAB1', 'BRAF', 'IL6ST', 'MAPK6', 'FGF12', 'HRAS', 'FGFR2']",0.9985648620835477,0,0,11
523,Heart Development WP1591,0.965525695848328,0.28174150177574836,0.009884214108395229,['MEF2C'],0.9985648620835477,0,0,1
524,Kallmann's Syndrome WP5074,0.965525695848328,0.28174150177574836,0.009884214108395229,['PIK3CA'],0.9985648620835477,0,0,1
525,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9673668294194787,0.48246951219512196,0.01600713588971322,"['RPTOR', 'MAP1LC3A', 'GTPBP2', 'ACACA', 'FTL']",0.9985648620835477,0,0,5
526,T-cell receptor (TCR) signaling pathway WP69,0.9700062787510921,0.5400686760778329,0.01644656804021866,"['CDC42', 'MAP2K1', 'TGFB1', 'ITPR1', 'FYN', 'GAB2', 'HRAS', 'NFKB1']",0.9985648620835477,0,0,8
527,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9700831320472817,0.4054226961157654,0.01231410951013192,"['RAC1', 'NFKB1', 'NFKBIB']",0.9985648620835477,0,0,3
528,Complement and Coagulation Cascades WP558,0.9733974691104046,0.26003980798501347,0.007011396559656962,['CLTC'],0.9985648620835477,0,0,1
529,Purinergic signaling WP4900,0.9733974691104046,0.26003980798501347,0.007011396559656962,['P2RY14'],0.9985648620835477,0,0,1
530,Breast cancer pathway WP4262,0.974847139686052,0.5925024795437639,0.015093763715574275,"['NCOA1', 'MAP2K1', 'GADD45A', 'CETN3', 'BRAF', 'IGF1R', 'CDK6', 'PIK3CA', 'RPS6KB1', 'AKT3', 'BAX', 'HRAS', 'SKP1']",0.9985648620835477,0,0,13
531,Ethanol effects on histone modifications WP3996,0.9748875127911774,0.33791397030833653,0.008594228904915248,"['KAT2B', 'AHCY']",0.9985648620835477,0,0,2
532,MTHFR deficiency WP4288,0.9748875127911774,0.33791397030833653,0.008594228904915248,"['EHMT1', 'CYCS']",0.9985648620835477,0,0,2
533,Oxysterols derived from cholesterol WP4545,0.9748875127911774,0.33791397030833653,0.008594228904915248,"['EBP', 'DBP']",0.9985648620835477,0,0,2
534,Neural Crest Differentiation WP2064,0.9765489796348322,0.4822722073961113,0.011444498677989792,"['CDH2', 'MITF', 'TCF4', 'NFKB1', 'FGFR2', 'SOX5']",0.9985648620835477,0,0,6
535,Canonical and non-canonical Notch signaling WP3845,0.979472230184278,0.24143835616438356,0.005007767833110167,['MFAP1'],0.9985648620835477,0,0,1
536,Gastric Cancer Network 1 WP2361,0.979472230184278,0.24143835616438356,0.005007767833110167,['MCM4'],0.9985648620835477,0,0,1
537,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.979472230184278,0.24143835616438356,0.005007767833110167,['RBBP4'],0.9985648620835477,0,0,1
538,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.979472230184278,0.24143835616438356,0.005007767833110167,['SRXN1'],0.9985648620835477,0,0,1
539,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.979472230184278,0.24143835616438356,0.005007767833110167,['PPARA'],0.9985648620835477,0,0,1
540,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.979472230184278,0.24143835616438356,0.005007767833110167,['PDHA1'],0.9985648620835477,0,0,1
541,Vitamin A and carotenoid metabolism WP716,0.979472230184278,0.24143835616438356,0.005007767833110167,['SULT1A1'],0.9985648620835477,0,0,1
542,Wnt Signaling Pathway WP363,0.9803854419650916,0.44422938061617456,0.008799951482696673,"['CDK6', 'PRKCA', 'PPARG', 'TCF4', 'RAC1']",0.9985648620835477,0,0,5
543,Fas ligand pathway and stress induction of heat shock proteins WP314,0.9835042144435114,0.3618621477532369,0.006018981931477431,"['CYCS', 'SPTAN1', 'ACTG1']",0.9985648620835477,0,0,3
544,Notch Signaling WP268,0.9835042144435114,0.3618621477532369,0.006018981931477431,"['KAT2B', 'NUMBL', 'NUMB']",0.9985648620835477,0,0,3
545,Wnt signaling WP428,0.98385055818541,0.5145685082158106,0.008377826359395189,"['PPP3CA', 'SFRP1', 'CAMK2D', 'CCND2', 'PLCB4', 'PRKCA', 'RAC1', 'PRICKLE1', 'PLCB1']",0.9985648620835477,0,0,9
546,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9841600878174976,0.22531709791983764,0.003597571474230091,['BAX'],0.9985648620835477,0,0,1
547,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9865209414279972,0.34934474879848726,0.004740861774198863,"['HSP90AA1', 'BAX', 'MAP3K5']",0.9985648620835477,0,0,3
548,Differentiation Pathway WP2848,0.9877775848655203,0.21121099695585996,0.0025974143582812755,['TGFB1'],0.9985648620835477,0,0,1
549,Mitochondrial Gene Expression WP391,0.9877775848655203,0.21121099695585996,0.0025974143582812755,['PPP3CA'],0.9985648620835477,0,0,1
550,16p11.2 distal deletion syndrome WP4950,0.9905690384348468,0.19876443728176202,0.0018834350966199214,['CD81'],0.9985648620835477,0,0,1
551,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9905690384348468,0.19876443728176202,0.0018834350966199214,['MAP1LC3A'],0.9985648620835477,0,0,1
552,Wnt signaling in kidney disease WP4150,0.9905690384348468,0.19876443728176202,0.0018834350966199214,['MAPK10'],0.9985648620835477,0,0,1
553,Joubert Syndrome WP4656,0.9910108179276962,0.46515544211869647,0.004200273886070157,"['KAT5', 'TCTN3', 'CSPP1', 'BBS9', 'PDE6B', 'CEP41', 'CEP290', 'ATF4']",0.9985648620835477,0,0,8
554,Glycerolipids and Glycerophospholipids WP4722,0.9927230152691117,0.18770082868256385,0.0013708901091749421,['CDIPT'],0.9985648620835477,0,0,1
555,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9927230152691117,0.18770082868256385,0.0013708901091749421,['EP300'],0.9985648620835477,0,0,1
556,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9927230152691117,0.18770082868256385,0.0013708901091749421,['RUNX1T1'],0.9985648620835477,0,0,1
557,Genes related to primary cilium development (based on CRISPR) WP4536,0.9953552904450417,0.49293083683607186,0.00229485416857417,"['DYNC2H1', 'DYNC2LI1', 'KIF3B', 'WDR60', 'TCTN3', 'IFT172', 'FBF1', 'WDR19', 'CDK20', 'SCLT1', 'BBS9', 'TXNDC15']",0.9985648620835477,0,0,12
558,Nanoparticle triggered autophagic cell death WP2509,0.9956674594045213,0.16889269406392693,0.0007333241812927697,['MAP1LC3A'],0.9985648620835477,0,0,1
559,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9967817105441129,0.3512846163617886,0.001132358684792611,"['CDK8', 'SFRP1', 'CCND2', 'CDK6', 'HNRNPK']",0.9985648620835477,0,0,5
560,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9998419074383645,0.1605126253013577,2.537785818688947e-05,"['SFRP1', 'CCND2']",0.9998419074383645,0,0,2
